OrthoRep: A Complete Guide to In Vivo Continuous Evolution for Protein Engineering and Drug Discovery

Harper Peterson Jan 12, 2026 105

This comprehensive guide explores the OrthoRep in vivo evolution platform, a revolutionary system for continuous, error-prone replication of orthogonal DNA plasmids in yeast.

OrthoRep: A Complete Guide to In Vivo Continuous Evolution for Protein Engineering and Drug Discovery

Abstract

This comprehensive guide explores the OrthoRep in vivo evolution platform, a revolutionary system for continuous, error-prone replication of orthogonal DNA plasmids in yeast. Designed for researchers, scientists, and drug development professionals, we detail its foundational principles, including the orthogonal DNA polymerase-plasmid pair derived from a linear mitochondrial plasmid. We provide methodological insights for applications like antibody affinity maturation and enzyme engineering, address common troubleshooting and optimization strategies, and validate its performance against other continuous evolution systems like PACE. The article concludes by synthesizing OrthoRep's unique advantages for generating evolved biomolecules directly in a eukaryotic host and its future implications for accelerating therapeutic and industrial protein development.

What is OrthoRep? Unveiling the Principles of In Vivo Continuous Evolution

Application Notes and Protocols

Thesis Context: This document details the experimental framework for utilizing OrthoRep, a continuous in vivo evolution platform, to drive protein and pathway evolution for applications in basic science and drug discovery. The system’s orthogonal DNA polymerase-plasmid pair enables hypermutation of target genes without affecting the host genome, allowing for long-term, adaptive evolution experiments.

1. System Overview and Key Data OrthoRep comprises two core components: 1) a cytoplasmic linear plasmid (p1) that replicates independently of nuclear DNA, and 2) an orthogonal DNA polymerase (DNAP) derived from the Thermococcus sp. 9°N virus, which is engineered to specifically replicate p1. Error-prone mutants of this DNAP (e.g., DL5, AF) are installed in the host yeast nucleus, directing targeted hypermutation of genes cloned into p1.

Table 1: OrthoRep System Components and Performance Metrics

Component Variant/Description Key Property/Quantitative Data Primary Function
Orthogonal Plasmid p1 (linear, 13.5 kb) Copy Number: ~100 copies/cell; Stability: >99.9% retained per generation. Carrier for gene(s) of interest (GOI) to be evolved.
Wild-Type Ortho DNAP TP-DNAP (Wild-type) Error Rate: ~10^-6 errors/base (similar to host). Provides stable, low-error-rate replication of p1 plasmid.
Error-Prone Ortho DNAP DL5 mutant (L744M/D580A) Error Rate: ~10^-5 errors/base; ~10^5-fold more mutations on p1 vs. genome. Drives continuous, targeted mutagenesis of GOI on p1.
Error-Prone Ortho DNAP AF mutant (L744M/D580A/A583F) Error Rate: ~10^-4 errors/base. Enables ultra-high mutagenesis for shorter evolution campaigns.
Host Strain S. cerevisiae BY4741 w/ p1 Genotype: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 + cytoplasmic p1. Provides cellular machinery and harbors the orthogonal plasmid.

2. Core Protocol: Establishing an OrthoRep-Driven Evolution Experiment

Protocol 2.1: Cloning Gene of Interest (GOI) into the p1 Plasmid

  • Objective: Insert the GOI into the p1 acceptor site, replacing the default URA3 marker.
  • Materials:
    • p1 Plasmid DNA: Isolated from yeast using a standard yeast plasmid miniprep protocol.
    • GOI Amplification Primers: Primers containing 40-50 bp homology arms to the p1 insertion locus.
    • Yeast Transformation Mix: PEG/LiOAc/ssDNA-based transformation reagents.
    • Selection Media: Synthetic Defined (SD) -His/-Leu/-Met media for maintenance; 5-Fluoroorotic Acid (5-FOA) plates for selection against URA3.
  • Method:
    • Amplify the GOI with the designed homology arms.
    • Co-transform the linearized p1 plasmid (or in vivo linearized via CRISPR) and the GOI PCR product into the OrthoRep host strain already harboring the error-prone DNAP (e.g., DL5).
    • Plate transformations onto 5-FOA plates to select for cells that have lost the p1-URA3 and gained the p1-GOI. Incubate at 30°C for 2-3 days.
    • Screen colonies by colony PCR to confirm correct integration of the GOI into p1.

Protocol 2.2: Continuous In Vivo Evolution under Selective Pressure

  • Objective: Propagate yeast harboring the p1-GOI and error-prone Ortho DNAP under defined selection to evolve improved phenotypes.
  • Materials:
    • Evolution Culture Vessels: 96-deep well plates or glass test tubes.
    • Selection Media: Appropriate SD media lacking a nutrient or containing a drug/stress agent (e.g., inhibitory compound for drug resistance evolution).
    • Liquid Handling System: Manual pipettes or automated systems for serial passaging.
  • Method:
    • Inoculate a single confirmed colony into 1 mL of non-selective SD media. Grow to saturation (24-48 hrs) at 30°C with shaking.
    • Dilution & Passage: Every 24-48 hours, perform a dilution (typically 1:100 to 1:1000) into fresh media containing the selective pressure. The dilution factor determines population size and bottleneck stringency.
    • Monitoring: Track culture density (OD600). A sustained increase in growth rate or yield under selection indicates adaptive evolution.
    • Continue serial passaging for the desired duration (e.g., 10-100+ generations).
    • Periodically archive samples (e.g., glycerol stocks) at -80°C for retrospective analysis.

Protocol 2.3: Harvesting and Sequencing Evolved p1 Plasmids

  • Objective: Isolate p1 DNA from evolved populations/clones and identify mutations.
  • Materials:
    • Yeast Plasmid Miniprep Kit: Specifically designed to isolate yeast plasmids (e.g., Zymoprep Yeast Plasmid Miniprep II).
    • p1-specific Sequencing Primers: Targeting the GOI and p1 backbone.
    • E. coli Strain for Plasmid Propagation: recA– strain (e.g., DH5α) for amplifying harvested p1 if needed for high-quality sequencing prep.
  • Method:
    • Isolate total yeast plasmid DNA from evolved cultures or single colonies.
    • Transform the isolated DNA into competent E. coli to recover the cytoplasmic p1 plasmid (which replicates in E. coli via its embedded origin). Alternatively, amplify the GOI directly from yeast genomic/plasmid prep via PCR for sequencing.
    • Sanger sequence (for clones) or prepare libraries for Next-Generation Sequencing (NGS) (for populations) of the p1-GOI region.
    • Align sequences to the parent GOI to identify evolved mutations.

3. Visualization of OrthoRep System and Workflow

G cluster_host S. cerevisiae Host Cell cluster_nucleus Nucleus cluster_cytoplasm Cytoplasm NuclearGenome Nuclear Genome (Low Mutation Rate) OrthoDNAP_Gene Error-Prone Ortho DNAP Gene (e.g., DL5 mutant) OrthoDNAP_Protein Ortho DNAP Protein (Error-Prone) OrthoDNAP_Gene->OrthoDNAP_Protein Transcription/Translation p1_plasmid Orthogonal Plasmid (p1) ~100 copies/cell Contains Gene of Interest (GOI) Ribosomes Ribosomes p1_plasmid->Ribosomes mRNA SelectionPressure Selective Pressure (e.g., Drug, Pathway Demand) p1_plasmid->SelectionPressure Phenotype OrthoDNAP_Protein->p1_plasmid Orthogonal Replication (High Mutation Rate) EvolvedGOI Evolved GOI on p1 (Accumulated Mutations) SelectionPressure->EvolvedGOI Drives Selection

OrthoRep System Mechanism & Evolution Drive

G Start Clone GOI into p1 plasmid Step1 Transform into yeast with error-prone Ortho DNAP Start->Step1 Step2 Serial passaging in selective media (10s-1000s of generations) Step1->Step2 Step3 Monitor phenotype (e.g., growth rate) Step2->Step3 Decision Improved phenotype achieved? Step3->Decision Decision:s->Step2:n No Step4 Isolate p1 plasmid from population/clones Decision->Step4 Yes Step5 Sequence GOI Identify mutations Step4->Step5 End Validate mutations & characterize variants Step5->End

OrthoRep Continuous Evolution Workflow

4. The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Materials for OrthoRep Experiments

Reagent/Material Function/Description Example/Supplier Note
OrthoRep Host Strain S. cerevisiae strain with chromosomally integrated error-prone Ortho DNAP and cytoplasmic p1 plasmid. Available from the original developers or constructed via published genetic strategies.
p1 Plasmid Acceptor Vector Engineered linear p1 plasmid with a cloning cassette (e.g., URA3 marker flanked by homology arms). Used as the backbone for GOI insertion via homologous recombination.
Error-Prone Ortho DNAP Variants Plasmids or integrated genes encoding mutant DNAPs (DL5, AF). DL5 is standard for long-term evolution; AF for very high mutagenesis.
5-Fluoroorotic Acid (5-FOA) Selective agent. Cells expressing URA3 convert 5-FOA to a toxic metabolite; used to select for p1-GOI replacements. Critical for swapping the GOI into the p1 plasmid.
Yeast Plasmid Miniprep Kit Reagents for isolating yeast plasmids, enriching for the cytoplasmic p1 DNA. Zymoprep or similar. Standard E. coli kits do not efficiently recover p1.
Homology-Directed Cloning Reagents High-fidelity PCR mix, LiOAc/PEG transformation reagents, single-stranded carrier DNA. For efficient, scarless integration of the GOI into p1 in vivo.
Deep-Well Culture Plates For high-throughput parallel evolution experiments in liquid media. Enables evolution of multiple lineages or under different conditions simultaneously.

Application Notes

Within the broader context of developing OrthoRep, a revolutionary continuous in vivo evolution system, the orthogonal DNA polymerase (pGKL1 Pol) and its target plasmid represent the core synthetic biology components. The system's power derives from the compartmentalization of genetic information and its replication machinery. pGKL1 Pol, derived from the cytoplasmic linear plasmid pGKL1 of Kluyveromyces lactis, is an error-prone B-family DNA polymerase. It is engineered to exclusively and orthogonally replicate a distinct, engineered cytoplasmic plasmid (the "target" plasmid) in the yeast Saccharomyces cerevisiae, while leaving the host's nuclear genome untouched. This physical and functional separation enables the user to impose a mutational burden (10^-5 to 10^-4 mutations per base per replication) on genes of interest cloned onto the target plasmid, while cellular selection pressures enrich for beneficial variants. This system is central to accelerating protein and metabolic pathway evolution for drug discovery and biocatalyst development.

Table 1: Key Characteristics of the OrthoRep System Components

Component Key Property Value / Description Functional Implication
pGKL1 Pol Origin Kluyveromyces lactis plasmid pGKL1 Naturally cytoplasmic in yeast, enabling orthogonal replication.
Fidelity Low (error-prone) Introduces ~10^-5 mutations/base/replication, driving evolution.
Processivity High Efficiently replicates entire target plasmid (ca. 8 kb).
Orthogonality High Does not recognize or replicate nuclear S. cerevisiae chromosomes.
Target Plasmid Type Engineered Cytoplasmic Plasmid Replicates in cytoplasm, independent of nuclear processes.
Size ~8 kilobase pairs (kb) Optimized for stability and cargo capacity (GOI + essential sequences).
Copy Number High (~10-30 copies/cell) Enables strong phenotype expression and selection.
Essential Genes URA3, tRNA suppressor Provides selection for plasmid retention and optional suppression.
Evolution System Mutation Rate ~10^-5 per base per replication ~100,000x higher than host genome; enables rapid diversity generation.
Selection Linkage Direct Mutated gene is linked to plasmid essential for survival.

Experimental Protocols

Protocol 1: Establishing the OrthoRep Evolution Platform in S. cerevisiae

Objective: To generate a yeast strain harboring the orthogonal polymerase system and to clone a gene of interest (GOI) onto the target plasmid for evolution.

Materials:

  • S. cerevisiae strain with chromosomal integration of pGKL1 Pol expression cassettes (e.g., strain expressing pGKL1 Pol and pGKL1 TP).
  • Target plasmid backbone (linearized).
  • Gene of interest (GOI) PCR product with homology arms.
  • Yeast transformation mix (PEG, lithium acetate, single-stranded carrier DNA).
  • Synthetic dropout media lacking uracil (-Ura).

Procedure:

  • Prepare DNA: Amplify your GOI with 40-bp homology arms matching the insertion site on the linearized target plasmid backbone.
  • Yeast Transformation: a. Grow the recipient yeast strain to mid-log phase. b. Harvest cells and prepare competent cells using the lithium acetate method. c. Co-transform 100 ng of linearized target plasmid backbone and 500 ng of GOI PCR product. d. Heat shock at 42°C for 40 minutes. e. Plate transformation mix onto -Ura agar plates to select for cells that have taken up and are maintaining the target plasmid.
  • Validation: a. After 3 days, pick colonies and inoculate -Ura liquid media. b. Isolate cytoplasmic plasmid DNA via a miniprep protocol that enriches for episomal DNA (e.g., Zymoprep). c. Transform isolated DNA into E. coli for amplification and Sanger sequence the GOI to confirm cloning.

Protocol 2: Continuous In Vivo Evolution of a GOI

Objective: To apply selective pressure to a population of OrthoRep yeast to evolve an improved protein function.

Materials:

  • Yeast culture from Protocol 1 (starter culture).
  • Appropriate selective media or condition (e.g., antibiotic, toxic metabolite, non-native carbon source).
  • Shaking incubator.
  • -Ura media for passaging.

Procedure:

  • Inoculation: Inoculate 5 mL of -Ura media with a single colony from Protocol 1. Grow for 24-48 hours to saturation.
  • Initiate Evolution: a. Dilute the saturated culture 1:1000 into fresh -Ura media containing the selective agent at a concentration that inhibits growth of the starting strain. b. Incubate at 30°C with shaking.
  • Continuous Passaging: a. Monitor culture density (OD600). b. Once growth is observed (indicating potential adaptation), or after a fixed period (e.g., 5-7 days), subculture by diluting the growing culture 1:1000 into fresh selective media. c. Repeat passaging for 10-50 cycles, periodically archiving glycerol stocks.
  • Screening & Analysis: a. Plate evolved populations on -Ura plates to obtain single colonies. b. Screen colonies for improved phenotype. c. Isolate target plasmid from improved clones, sequence the GOI to identify mutations, and characterize the evolved protein.

Visualizations

G HostGenome Host Nuclear Genome HostReplication Accurate Replication HostGenome->HostReplication OrthoPol Orthogonal Polymerase (pGKL1 Pol) TargetPlasmid Target Plasmid (8 kb, cytoplasmic) OrthoPol->TargetPlasmid Exclusively Replicates OrthoReplication Error-Prone Replication (High Mutation Rate) TargetPlasmid->OrthoReplication GOI Gene of Interest (GOI) GOI->TargetPlasmid Cloned Into HostPol Host DNA Pols HostPol->HostGenome Replicates

Title: OrthoRep System Core Mechanism

G Start Clone GOI into Target Plasmid Transform Transform into OrthoRep Yeast Strain Start->Transform Culture Culture under Selective Pressure Transform->Culture PlasmidRep Orthogonal Pol Replicates & Mutates Plasmid Culture->PlasmidRep In vivo Growth Beneficial Mutants Outgrow Population PlasmidRep->Growth Continuous Cycles Harvest Harvest & Isolate Target Plasmid Growth->Harvest Sequence Sequence GOI Identify Mutations Harvest->Sequence Characterize Characterize Evolved Protein Sequence->Characterize

Title: OrthoRep Continuous In Vivo Evolution Workflow

The Scientist's Toolkit

Table 2: Essential Research Reagent Solutions for OrthoRep Experiments

Reagent / Material Function Key Consideration
OrthoRep Yeast Strain Engineered S. cerevisiae host with chromosomally integrated pGKL1 Pol/TP genes. Base platform; ensures orthogonal replication. Must be maintained under appropriate selection.
Target Plasmid Backbone ~8 kb cytoplasmic plasmid containing URA3 and cloning site. Vehicle for the GOI. Must be linearized for homologous recombination cloning in yeast.
Yeast Transformation Kit Lithium acetate/PEG-based reagents and carrier DNA. Enables efficient co-transformation of plasmid backbone and GOI insert.
Cytoplasmic Plasmid Prep Kit Specialized kit (e.g., Zymoprep Yeast Plasmid Miniprep II). Isletes target plasmid away from the large host nuclear genome for analysis in E. coli.
Selection Agent Antibiotic, metabolite, or condition imposing desired selective pressure. Defines the evolutionary objective. Concentration must be carefully titrated.
-Ura Dropout Media Synthetic complete media lacking uracil. Selects for and maintains the target plasmid (via URA3 marker) in all cultures.
High-Fidelity PCR Mix For error-free amplification of GOI with homology arms. Critical for preparing the DNA fragment for in vivo gap repair cloning.
Gateway Cloning System (Optional) For in vitro assembly of GOI into a donor vector first. Alternative, higher-efficiency cloning method before yeast transformation.

Application Notes

Within the context of OrthoRep research, the system's core innovation is the harnessing of a dedicated, orthogonal DNA polymerase-plasmid pair in yeast (Saccharomyces cerevisiae) for continuous targeted mutagenesis. The cytoplasmic linear plasmid pGKL1 (or its engineered derivative, p1) is replicated by an error-prone DNA polymerase (polymerase γ, or Polγ), which is encoded by the plasmid itself. This physical and genetic separation from the host's high-fidelity nuclear genome replication allows for the continuous and rapid evolution of genes of interest (GOIs) cloned into the plasmid, without compromising host viability.

Key Quantitative Data Summary

Parameter Value/Range Notes / Experimental Condition
Mutation Rate (Polγ) ~10⁻⁵ substitutions per base per replication ~100,000-fold higher than host nuclear replication.
Orthogonal Plasmid Copy Number 60-100 copies/cell Cytoplasmic, linear p1/pGKL1-derived plasmid.
Targeted Gene Size Capacity Up to ~8 kb For gene(s) of interest cloned into the plasmid.
Evolution Rate 10⁻³ to 10⁻⁵ mutations per gene per generation Enables full library saturation of a 1 kb gene in ~1 week of continuous growth.
Selection Throughput >10¹⁰ mutant variants Achievable in standard lab culture volumes (~10 mL).
Host Strain S. cerevisiae BY4741 (or other ura3Δ) Requires uracil auxotrophy for plasmid selection.

Protocols

Protocol 1: Cloning a Gene of Interest into the OrthoRep Plasmid

Objective: To insert a target gene into the OrthoRep plasmid (p1 or p2) for subsequent continuous evolution.

Materials (Research Reagent Solutions):

  • OrthoRep Plasmid Kit: Contains linearized p1 vector with multicloning site (MCS) and homology arms for in vivo assembly.
  • Host Yeast Strain: S. cerevisiae BY4741 ura3Δ.
  • Gene of Interest (GOI) Amplification Mix: High-fidelity PCR reagents with primers containing 40 bp homology to vector MCS.
  • Yeast Transformation Mix: LiAc, PEG 3350, single-stranded carrier DNA.
  • Selection Media: Synthetic Complete (SC) media lacking uracil (SC -Ura).
  • Plasmid Recovery E. coli Strain: Specific strains (e.g., DH10B) for amplifying yeast-recovered plasmids.

Procedure:

  • Amplify your GOI using primers that add 40 bp homology arms matching the sequences flanking the MCS in the OrthoRep p1 plasmid.
  • Co-transform 100-500 ng of the linearized p1 vector and the purified GOI PCR product (molar ratio ~1:3) into the competent BY4741 yeast strain using the standard LiAc/PEG method.
  • Plate the transformation mixture onto SC -Ura agar plates. Incubate at 30°C for 48-72 hours.
  • Screen colonies by colony PCR or direct sequencing to confirm correct integration of the GOI into the plasmid.
  • To verify plasmid structure, recover the plasmid from yeast into E. coli by isolating total yeast DNA and transforming into a special E. coli strain capable of propagating linear plasmids, followed by diagnostic restriction digest.

Protocol 2: Continuous In Vivo Evolution and Variant Harvest

Objective: To propagate yeast carrying the OrthoRep-GOI plasmid under selective conditions to accumulate mutations and harvest evolved variants.

Materials:

  • Starter Culture: Yeast clone from Protocol 1.
  • Evolution Media: SC -Ura broth, optionally containing a selective pressure (e.g., sub-inhibitory concentration of a drug, non-preferred carbon source).
  • Propagation Tubes: 14 mL culture tubes or deep-well plates.
  • Dilution Buffers: Sterile 1X PBS or water.
  • Plasmid Harvest Kit: Yeast plasmid extraction kit or glass bead lysis reagents.

Procedure:

  • Inoculate 5 mL of SC -Ura broth with a single confirmed colony. Grow overnight at 30°C with shaking.
  • Daily Serial Propagation: Each day, dilute the saturated culture 1:100 to 1:1000 into fresh SC -Ura broth (with or without selective pressure). Maintain for the desired number of generations (e.g., 20-100 generations).
  • Variant Sampling: At intervals (e.g., every 20 generations), harvest 1-2 mL of culture. Isolate total DNA using a yeast plasmid extraction protocol that enriches for the cytoplasmic linear plasmid.
  • The GOI can now be PCR-amplified directly from the harvested plasmid DNA pool for next-generation sequencing to profile the mutation spectrum or cloned into an expression vector for functional screening of individual variants.

Visualizations

G Start Start Continuous Evolution P1 Clone GOI into OrthoRep Plasmid Start->P1 P2 Transform into S. cerevisiae Host P1->P2 P3 Daily Serial Propagation (1:1000 dilution) P2->P3 P4 Selective Pressure? (e.g., Drug, Substrate) P3->P4 P5 Yes: Applied P4->P5   P6 No: Neutral Drift P4->P6   P7 Error-Prone Polγ Replicates Plasmid P5->P7 P6->P7 P8 Mutations Accumulate in GOI over generations P7->P8 Feedback Loop P8->P3 Feedback Loop P9 Harvest Plasmid DNA at Intervals P8->P9 P10 Sequence Pool or Screen Individual Variants P9->P10

Title: OrthoRep Continuous Evolution Workflow

G cluster_host S. cerevisiae Host Cell cluster_nucleus Nucleus cluster_cytoplasm Cytoplasm (OrthoRep System) N_Genome High-Fidelity Genome Replication N_Pol Pol δ/ε (Low Error Rate) N_Pol->N_Genome Replicates C_Plasmid Linear Plasmid (p1) Harboring GOI Mut_GOI Evolving Gene of Interest (GOI) C_Plasmid->Mut_GOI Encodes C_Pol Orthogonal Polγ (Error-Prone) C_Pol->C_Plasmid Replicates

Title: Orthogonal Replication System In Vivo

The Scientist's Toolkit: Essential Research Reagents

Item Function in OrthoRep Experiments
Orthogonal Plasmid (p1/p2) Engineered linear cytoplasmic plasmid; the mutable vector carrying the gene of interest.
S. cerevisiae BY4741 (ura3Δ) Standard host strain; uracil auxotrophy allows selection for the URA3-marked OrthoRep plasmid.
Error-Prase Polγ The mutant DNA polymerase (D322A, L324M) responsible for the high, targeted mutation rate on the plasmid.
SC -Ura Media Selective growth medium maintains plasmid pressure and supports long-term propagation.
LiAc/PEG Transformation Kit Standard yeast chemical transformation method for introducing the linear plasmid DNA.
Linear Plasmid Recovery E. coli Specialized bacterial strain for amplifying the yeast-recovered linear plasmid for analysis.
Selective Agent (e.g., Drug) Applied during propagation to bias evolution toward desired functional phenotypes.
Homology Assembly Primers Designed with 40 bp ends for seamless cloning of GOIs into the OrthoRep plasmid via in vivo recombination.

OrthoRep is a revolutionary in vivo continuous evolution system that originated from the discovery of a linear cytoplasmic plasmid in the yeast Saccharomyces cerevisiae. This plasmid, with its error-prone DNA polymerase (pPol1), provides a natural platform for hypermutating genes of interest while the host genome remains stable. Within the context of thesis research on OrthoRep, these application notes detail its utility for evolving biomolecules with new functions, particularly for drug discovery and protein engineering.

Core Advantages:

  • Continuous in vivo Evolution: Enables rapid exploration of vast sequence space without repeated cloning.
  • Genomic Orthogonality: The target gene is mutagenized on the orthogonal plasmid, leaving the host genome untouched, ensuring cellular viability.
  • High Mutational Throughput: pPol1’s error rate (~10^-5 mutations/base/replication) allows for the generation of complex, multi-mutant libraries in a single round.
  • Direct Selection Linkage: Evolved variants are automatically linked to their genetic material, streamlining identification.

Primary Applications in Drug Development:

  • Antibody & Affinity Reagent Evolution: Rapid maturation of binding affinity and specificity.
  • Enzyme Engineering: For drug metabolism (P450s), prodrug activation, or synthesis of complex therapeutic molecules.
  • Viral Target Evolution: Evolving viral proteins (e.g., HIV envelope, SARS-CoV-2 RBD) under drug pressure to study resistance mechanisms.
  • Membrane Protein Engineering: In vivo system is ideal for evolving G Protein-Coupled Receptors (GPCRs) and transporters.

Table 1: Key Performance Metrics of OrthoRep System

Metric Value / Description Implication for Evolution
Mutation Rate (pPol1) ~10^-5 per base per replication 10^3-10^5x higher than host. Enables rapid diversity generation.
Plasmid Copy Number ~100 copies per cell (p1 derivative) High template load increases library size and selection stringency.
Cargo Gene Capacity Up to ~5 kb (p6 plasmid) Can evolve large genes or multi-gene pathways.
Evolution Rate ~10^-3 mutations/bp/day Allows for 10+ sequential mutations in a target gene over weeks.
Max Library Diversity >10^10 unique variants Comprehensive exploration of protein sequence space.

Table 2: Comparison of OrthoRep to Other Continuous Evolution Platforms

Platform (Organism) Mutagenesis Target Max Gene Size Key Distinction
OrthoRep (Yeast) Linear cytoplasmic plasmid ~5 kb In vivo eukaryotic host; ideal for eukaryotic protein folding/post-translational modifications.
Phage-Assisted Continuous Evolution (PACE) (E. coli) Bacteriophage genome ~1-2 kb Extremely fast cycles (~1-2 hrs); requires specialized lagoon apparatus.
EvolvR (E. coli) Defined genomic locus Unlimited in theory Uses engineered nickase-polymerase fusion; genome-integrated.
TRIDENT (Mammalian) Episomal plasmid ~4 kb Uses APOBEC cytidine deaminase; base-editing focused (C->T, G->A).

Experimental Protocols

Protocol 1: OrthoRep System Setup for Protein Evolution Objective: Clone a gene of interest (GOI) into the OrthoRep plasmid and establish the engineered yeast strain for evolution.

Materials:

  • S. cerevisiae strain harboring native p1 and p2 plasmids (e.g., BY4733 derivative).
  • p6 Plasmid Vector: Orthogonal plasmid with cloning site (e.g., MCS), auxotrophic marker (e.g., URA3), and pPol1.
  • GOI Amplification Primers with 40bp homology to p6 MCS.
  • Yeast transformation reagents (LiAc/SS carrier DNA/PEG method).
  • Synthetic Dropout (SD) media lacking uracil (-Ura) for selection.

Procedure:

  • Amplify the GOI using PCR, adding 40bp homology arms to the p6 MCS.
  • Linearize the p6 plasmid vector at the MCS using appropriate restriction enzymes.
  • Co-transform 100-500ng of linearized p6 vector and 100-200ng of purified GOI PCR product into the yeast strain using a standard LiAc transformation protocol.
  • Plate transformation mix onto SD -Ura agar plates. Incubate at 30°C for 2-3 days.
  • Screen colonies by colony PCR or plasmid extraction/sequencing to confirm correct integration of the GOI into the p6 plasmid.
  • Inoculate a positive colony into SD -Ura liquid media to establish the starter evolution strain. Store glycerol stocks at -80°C.

Protocol 2: Continuous In Vivo Evolution with Serial Passaging Objective: Drive evolution of the GOI under a defined selective pressure.

Materials:

  • Starter evolution strain from Protocol 1.
  • Selective media applying the desired pressure (e.g., drug, toxic metabolite, non-native carbon source).
  • Non-selective SD -Ura media.
  • Deep-well plates or flasks for culture.

Procedure:

  • Inoculate the starter strain into non-selective SD -Ura media. Grow to saturation (24-48 hrs, 30°C).
  • Dilute the culture 1:100 or 1:1000 into selective media. This marks the start of evolution (Day 0).
  • Grow the culture until growth is observed (typically 24-96 hrs). This indicates the emergence of adaptive mutants.
  • Serial Passage: Dilute the grown culture 1:100 into fresh selective media. Repeat this passage step every 1-4 days for the duration of the evolution experiment (e.g., 2-8 weeks).
  • Periodically (e.g., every 5-10 passages), harvest cell pellets for analysis (plasmid extraction, sequencing) or archive glycerol stocks.

Protocol 3: Harvesting and Sequencing Evolved Variants Objective: Isolate the evolved p6 plasmid and identify mutations in the GOI.

Materials:

  • Zymolyase or Lyticase.
  • Yeast plasmid miniprep kit (designed for yeast).
  • E. coli strain for plasmid propagation.
  • PCR primers specific for GOI.
  • Next-generation sequencing (NGS) library prep kit.

Procedure:

  • From an evolved culture pellet, extract total yeast DNA using a standard yeast miniprep protocol with Zymolyase digestion to break cell walls.
  • Transform the extracted DNA (containing p6 plasmids) into competent E. coli to recover individual plasmid clones.
  • Prepare plasmid DNA from multiple E. coli colonies. Sanger sequence the GOI from each to assess diversity.
  • For a population view, perform PCR to amplify the GOI directly from the evolved yeast genomic DNA. Prepare an NGS library from the pooled amplicon and perform deep sequencing.
  • Analyze sequencing data to identify mutation frequency and patterns (e.g., convergent mutations).

Visualizations

orthorep_workflow Start Start: Native Yeast Strain Clone Clone GOI into OrthoRep p6 Plasmid Start->Clone Transform Yeast Transformation Clone->Transform Starter Starter Evolution Strain Transform->Starter Passage Serial Passage in Selective Media Starter->Passage Passage->Passage Repeat Harvest Harvest & Analyze Population Passage->Harvest Seq Deep Sequencing & Variant ID Harvest->Seq End Evolved Protein Seq->End

OrthoRep Continuous Evolution Workflow

orthorep_plasmid_mech cluster_host Host Nuclear Genome cluster_plasmid OrthoRep Plasmid (p1/p6) HostDNA Stable Nuclear DNA HostPol High-Fidelity DNA Pol HostDNA->HostPol Accurate Replication PlasmidDNA Linear Plasmid DNA Harboring GOI PlasmidPol Error-Prone pPol1 PlasmidDNA->PlasmidPol Error-Prone Replication MutantGOI Diverse Mutant GOI Library PlasmidPol->MutantGOI Generates

Orthogonal Plasmid Replication Mechanism

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for OrthoRep-Based Evolution

Item Function & Description Example/Supplier Note
OrthoRep Yeast Strain Host strain containing the native p1/p2 system. Foundation for engineering. BY4733 leu2Δ0 strain. Available from academic developers.
p6 Cloning Vector Engineered OrthoRep plasmid for GOI insertion. Contains URA3 marker and pPol1. Key plasmid; sequence verified. Request from developers or Addgene.
Error-Prone pPol1 The mutant DNA polymerase driving evolution. Integral part of the p6 plasmid system. Variants with different error rates/spectra may be available.
Yeast Transformation Kit For efficient introduction of linearized p6+GOI into yeast. High-efficiency LiAc/SS carrier DNA/PEG method reagents.
Synthetic Defined Media For selective growth and application of evolutionary pressure. -Ura dropout base; customizable with drugs, metabolites, etc.
Zymolyase/Lyticase Digests yeast cell wall for plasmid extraction. Essential for high-quality plasmid recovery from yeast.
Yeast Plasmid Miniprep Kit Isolates p6 plasmid from yeast cultures for analysis. Standard kits often modified with a bead-beating step.
NGS Library Prep Kit For deep sequencing of evolved gene populations from PCR amplicons. Amplicon-EZ or similar targeted sequencing kits.

Application Notes on the OrthoRepIn VivoEvolution System

The OrthoRep system is a revolutionary platform for continuous, targeted, and autonomous evolution of proteins in yeast (Saccharomyces cerevisiae). Its core advantages make it uniquely suited for exploring vast sequence spaces and evolving proteins with novel or enhanced functions, directly within a eukaryotic cellular environment. This aligns with the broader thesis that OrthoRep fundamentally shifts the paradigm of directed evolution by enabling long-term, user-defined evolutionary trajectories with minimal manual intervention.

Core Advantages Detailed:

  • Continuous Mutation: OrthoRep employs a hypermutator based on a orthogonal DNA polymerase-plasmid pair (p1 and p3 in cytoplasm). The error-prone OrthoRep polymerase, derived from the cytoplasmic linear plasmid of Saccharomyces kluyveri, replicates a specific cytoplasmic plasmid (p1) at rates ~100,000-fold higher than the nuclear genome. This allows the continuous accumulation of mutations in a target gene of interest (GOI) cloned into p1, without altering the host's genome. Mutational spectra (e.g., bias towards transitions) can be tuned by engineering the polymerase.

  • Selection in a Eukaryotic Host: The system operates within S. cerevisiae, providing the complex cellular machinery of a eukaryote—including chaperones, post-translational modifications (e.g., glycosylation, disulfide bond formation), and organelle-specific targeting. Proteins evolve in a functionally relevant context, increasing the likelihood of identifying variants that are functional and stable in higher eukaryotic systems (e.g., mammalian cells), a critical advantage for therapeutic protein development.

  • Hands-Off Operation: Once the initial genetic construct is established—with the GOI linked to a selectable marker (e.g., for metabolic complementation or drug resistance) on the hypermutable plasmid—the system can be propagated continuously. Serial passaging under selective pressure allows the automatic enrichment of beneficial mutants over time, enabling evolution over months or hundreds of generations with minimal researcher effort.

Quantitative Performance Data:

Table 1: OrthoRep System Performance Metrics

Parameter Value / Description Implication
Mutation Rate (Target Plasmid) ~10⁻⁵ mutations per base per replication ~100,000x higher than nuclear genome. Enables deep exploration of mutational space.
Mutation Spectrum (Typical) AT→GC, GC→AT transitions favored; tunable. Focuses diversity on potentially less disruptive changes; spectrum can be engineered.
Evolution Duration Weeks to months (>100 generations) Enables accumulation of multiple, potentially synergistic mutations (clonal expansion).
Throughput (Variants Screened) Effectively unlimited during continuous passaging. Surpasses the capacity of any manual screening or selection method.
Functional Success Rates High for in vivo fitness traits (e.g., drug resistance, enzymatic activity linked to growth). Evolution occurs under direct, biologically relevant selective pressure.

Protocols for Key Experiments

Protocol 1: Setting Up an OrthoRep-Driven Evolution for a Metabolic Enzyme

Objective: Evolve a plant cytochrome P450 enzyme for enhanced activity in yeast, using a auxotrophic complementation selection.

Materials (Research Reagent Solutions):

  • S. cerevisiae strain harboring OrthoRep system (e.g., ySHYi141).
  • Orthogonal plasmid p1 cloning vector.
  • Target P450 gene, yeast codon-optimized.
  • Yeast synthetic dropout media lacking uracil (SD -Ura) and lacking both uracil and the metabolite produced by the P450 (e.g., SD -Ura -Trp for tryptophan synthesis).
  • PCR reagents, Gibson Assembly or yeast homologous recombination reagents.
  • Sterile 96-deep well plates and liquid handling robot (for manual or automated passaging).

Methodology:

  • Clone Target Gene: Clone the P450 gene into the p1 plasmid downstream of a constitutive yeast promoter, replacing the default ADE2 marker. Fuse the P450 to a selectable marker gene (e.g., TRP1) via a self-cleaving 2A peptide or an IRES-like sequence to ensure linked inheritance.
  • Yeast Transformation: Transform the constructed p1 plasmid into the OrthoRep yeast strain using standard LiAc/SS carrier DNA/PEG method. Select on SD -Ura plates to maintain the p1 plasmid.
  • Initiate Evolution: Inoculate multiple (≥6) independent colonies into SD -Ura liquid media. After growth, wash cells and resuspend in the selective evolution media (SD -Ura -Trp). The initial strain will grow poorly.
  • Serial Passaging: Dilute cultures 1:50 to 1:100 into fresh selective media every 24-48 hours. Use automated systems or manual pipetting. Monitor OD600. Growth rates will typically increase over time as functional P450 variants evolve.
  • Harvest and Sequence: After desired number of passages (e.g., when growth saturation is rapid), isolate p1 plasmid DNA from population and individual clones. Sequence the P450 gene to identify evolved mutations.

Protocol 2: Isolation and Characterization of Evolved Variants

Objective: Isolate individual evolved clones and characterize their functional improvements.

Methodology:

  • Plasmid Rescue: At evolution endpoint, extract total yeast DNA. Use E. coli to rescue the cytoplasmic p1 plasmid by transforming electrocompetent E. coli with the yeast DNA prep and selecting on ampicillin.
  • Colony PCR & Sequencing: Pick individual E. coli colonies, perform colony PCR on the P450 insert, and send for Sanger sequencing. Align sequences to identify mutations.
  • Functional Assay: Retransform isolated p1 plasmids (or cloned mutant genes into fresh vectors) into naive OrthoRep yeast. Perform head-to-head growth competitions in selective media or measure specific product formation via HPLC/MS.

Visualizations

G node1 Step 1: Clone GOI + Selectable Marker into OrthoRep Plasmid (p1) node2 Step 2: Transform into OrthoRep Yeast Host node1->node2 node3 Step 3: Culture under Continuous Selective Pressure node2->node3 node4 OrthoRep Polymerase Continuously Mutates p1 node3->node4 enables node5 Yeast Host Provides Eukaryotic Machinery node3->node5 within node6 Step 4: Beneficial Mutants Outgrow Others node3->node6 node4->node6 generates diversity node5->node6 applies relevant filters node7 Step 5: Serial Passaging Enriches for Fittest node6->node7 node8 Output: Evolved Gene in p1 Plasmid node7->node8

Diagram 1: OrthoRep Hands-Off Evolution Workflow (92 chars)

G cluster_host Eukaryotic Yeast Host Cell cluster_nucleus Nucleus cluster_cytoplasm Cytoplasm Genome Nuclear Genome (Low Mutation Rate) PTM Chaperones, ER, Glycosylation, etc. Genome->PTM Encodes Host Machinery OrthoPoly OrthoRep Polymerase (High Error Rate) PlasmidP1 Target Plasmid (p1) [GOI + Marker] OrthoPoly->PlasmidP1 Replicates & Mutates PlasmidP1->PTM mRNA/Protein Selection In Vivo Selection (e.g., Growth Advantage) PTM->Selection Functional Protein Selection->PlasmidP1 Enriches Beneficial Plasmid Variants

Diagram 2: OrthoRep System in Eukaryotic Host Context (83 chars)

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Materials for OrthoRep Experiments

Item Function / Role in Experiment
OrthoRep Yeast Strain (e.g., ySHYi141) Engineered S. cerevisiae host containing the error-prone orthogonal polymerase and its template plasmid. The foundational chassis.
p1 Cloning Vector The cytoplasmic plasmid that is hypermutated. Used to clone the Gene of Interest (GOI) and a linked selectable marker.
p3 Plasmid / Helper Plasmids Encodes the orthogonal polymerase or other components necessary for the system's function. Often maintained under selection in the nucleus.
Specialized Dropout Media Used for selection: (i) to maintain plasmids; (ii) to apply evolutionary pressure (e.g., absence of a metabolite the GOI must produce).
Automated Cultivation System (e.g., turbidostat, robotic liquid handler) Enables consistent, high-throughput serial passaging over long periods for true "hands-off" operation.
Yeast Plasmid Rescue Kit Reagents/protocols for efficiently extracting the cytoplasmic p1 plasmid from yeast and transforming it into E. coli for sequencing and analysis.
Mutant Polymerase Variants Engineered versions of the OrthoRep polymerase with altered mutational spectra (e.g., more transversions, different biases) to tailor evolutionary exploration.

Implementing OrthoRep: Step-by-Step Protocols and Key Applications in Research

I. Introduction & Thesis Context

Within the broader thesis on advancing OrthoRep for in vivo continuous evolution, establishing a robust and stable orthogonal replication system in the yeast host (Saccharomyces cerevisiae) is the critical foundational step. OrthoRep comprises two main components: 1) the orthogonal DNA polymerase (DNAP)-plasmid pair derived from Thermus thermophilus (p1 and p2 plasmids replicated by the tDNAP), and 2) the host yeast chromosome. This system enables the continuous, rapid, and targeted evolution of genes of interest (GOIs) cloned on the orthogonal plasmid, independent of the host's genome replication. These application notes provide detailed protocols for engineering your yeast host strain to stably harbor the OrthoRep system.

II. Key Research Reagent Solutions

Reagent/Material Function in OrthoRep Establishment
Yeast Host Strain: BY4741 Δtrp1 Δleu2 Provides auxotrophic markers (TRP1, LEU2) for selection of orthogonal plasmids. Genome modifications are well-characterated in this background.
Orthogonal Plasmid System: p1 (Δori, Δtrp) & p2 (Δori, Δleu) Engineered plasmids from T. thermophilus. Lack yeast origins but carry tDNAP-recognized origins (ori). p1 carries TRP1, p2 carries LEU2 for selection.
tDNAP Expression Plasmid: pCM189-TEF1p-tDNAP-ADH1t (HIS3) A yeast episomal plasmid (with yeast 2µ origin) expressing the T. thermophilus DNAP under a doxycycline-repressible promoter. HIS3 marker for selection.
Linear Donor DNA Fragment: tRNA-scaffold-ADH1t-TEF1p-tDNAP-CYC1t For chromosomal integration of the tDNAP gene. Contains homology arms for targeted genomic integration.
Doxycycline Hyclate Small molecule used to repress tDNAP expression from the pCM189 plasmid during strain construction and to tune mutation rates.
YPAD & Synthetic Dropout Media (SD -Trp, -Leu, -His, -Trp/-Leu) For general yeast growth and selection of plasmids/integrations based on auxotrophic complementation.

III. Core Protocol: Engineering the Stable OrthoRep Host Strain

A. Goal: Generate a yeast strain where the tDNAP is stably integrated into the genome, constitutively expressing the polymerase to autonomously replicate the p1 and p2 orthogonal plasmids.

B. Detailed Stepwise Protocol

Step 1: Initial Transformation with tDNAP Expression Plasmid

  • Transform chemically competent BY4741 Δtrp1 Δleu2 cells with the pCM189-TEF1p-tDNAP-ADH1t plasmid using standard lithium acetate/PEG method.
  • Plate transformation on SD -His plates. Incubate at 30°C for 48-72 hours.
  • Pick and verify colonies by colony PCR for the presence of the tDNAP gene. Grow verified colonies in SD -His media with 2 µg/mL doxycycline to repress tDNAP expression.

Step 2: Consecutive Transformation with Orthogonal Plasmids

  • Prepare competent cells from a verified strain from Step 1.
  • Co-transform with both p1 (carrying TRP1) and p2 (carrying LEU2) orthogonal plasmids.
  • Plate on SD -Trp/-Leu plates containing 2 µg/mL doxycycline. Incubate at 30°C for 72-96 hours. The doxycycline represses tDNAP, preventing potential toxicity and allowing plasmid maintenance through selection only.
  • Pick double-positive colonies and verify presence of both plasmids by plasmid rescue or PCR.

Step 3: Genomic Integration of the tDNAP Gene

  • Design and PCR-amplify the linear donor DNA fragment for tDNAP integration. The fragment should contain: a genomic homology arm (targeting a neutral site like ho locus), the tDNAP expression cassette (TEF1 promoter-tDNAP-ADH1 terminator), and a dominant selection marker (e.g., kanMX).
  • Transform the strain from Step 2 (harboring p1, p2, and pCM189-tDNAP) with this linear fragment. Select on YPD plates containing Geneticin (G418).
  • Screen G418-resistant colonies for loss of the pCM189-tDNAP plasmid by replica-plating onto SD -His. Colonies that grow on G418 but not on SD -His have likely integrated tDNAP and lost the episomal plasmid.
  • Confirm genomic integration by colony PCR across both junctions of the integrated cassette.

Step 4: Curing the Episomal Plasmid & Final Validation

  • Grow the confirmed integrant strain from Step 3 in non-selective YPAD medium (without doxycycline) for ~10 generations.
  • Plate on YPAD for single colonies. Replica-plate onto SD -His to identify clones that have lost the pCM189 plasmid.
  • The final strain should be: His- (pCM189 cured), G418R (tDNAP integrated), and capable of growing on SD -Trp/-Leu (p1/p2 maintained).
  • Final Validation Test: Streak the final strain on SD -Trp/-Leu with and without doxycycline. Growth in both conditions confirms tDNAP is now constitutively expressed from the genome, replicating p1/p2 independent of the repressible promoter.

IV. Data Summary: Orthogonal Plasmid Characteristics

Table 1: Properties of the Orthogonal Replication System Components

Component Size (bp) Copy Number in Yeast Mutation Rate (vs. host genome) Key Genetic Elements
p1 Plasmid ~4,500 ~10 - 15 copies/cell ~10^5-fold higher T. thermophilus ori, TRP1, MCS for GOI
p2 Plasmid ~3,800 ~10 - 15 copies/cell ~10^5-fold higher T. thermophilus ori, LEU2
Host Chromosome ~12 Mb 1-2 copies 1x (baseline) Native yeast replication origins
tDNAP (genomic) ~2.5 kb (gene) N/A (constitutive) N/A Integrated TEF1p-tDNAP-ADH1t

V. Visualized Workflows and System Logic

G Start Parental Yeast Host BY4741 Δtrp1 Δleu2 Step1 Transform with pCM189-tDNAP (HIS3) Start->Step1 State1 Strain A: +tDNAP plasmid (+Dox) Step1->State1 Step2 Co-transform with p1 (TRP1) & p2 (LEU2) State1->Step2 State2 Strain B: +tDNAP plasmid + p1/p2 (+Dox) Step2->State2 Step3 Integrate tDNAP cassette into genome (G418R) State2->Step3 State3 Strain C: tDNAP integrated + p1/p2 + tDNAP plasmid Step3->State3 Step4 Cure pCM189 plasmid via non-selective growth State3->Step4 Final Final OrthoRep Host: Genomic tDNAP + p1/p2 (Dox independent) Step4->Final

Diagram 1: Orthogonal Host Strain Construction Workflow (76 chars)

G YeastGenome Yeast Nuclear Genome Native Replisome Chromosomal Origins Endogenous Genes Replication1 Replication YeastGenome:header->Replication1 OrthogonalSystem Orthogonal Replication System Constitutive tDNAP (Genomic Expression) T. thermophilus ori p1/p2 Plasmids (~10-15 copies) Gene of Interest (GOI) (for evolution) Replication2 Replication OrthogonalSystem:tdnap->Replication2 OrthogonalSystem:p1p2->Replication2 Mutations High-Rate Mutagenesis (~10⁻⁵ per bp) Replication2->Mutations Mutations->OrthogonalSystem:goi_plasmid  Targeted

Diagram 2: Orthogonal Replication System Logic in Final Host (75 chars)

Application Notes

This protocol details the construction of an evolvable plasmid for the directed evolution of genes in vivo using the OrthoRep system. OrthoRep employs an orthogonal error-prone DNA polymerase (DNAP) from the yeast Saccharomyces cerevisiae linear cytoplasmic plasmid pGKL, which replicates its associated DNA independently of the host genome with a high mutation rate (~10⁻⁵ substitutions per base). By cloning a gene of interest (GOI) into the orthogonal replicon, it can be subjected to continuous, targeted mutagenesis during host propagation, enabling the rapid discovery of evolved protein variants.

Key Advantages

  • Continuous In Vivo Mutagenesis: Once established, the system continuously generates diversity in the GOI without repeated library cloning.
  • Orthogonal Replication: The replicon’s independence from host genome replication allows for high, targeted mutation rates without compromising host viability.
  • Scalable Selection: Evolved plasmids are easily harvested from yeast, and the GOI can be shuttled to E. coli for high-throughput screening or functional assays.

Protocol: Cloning and Establishing the Evolvable Plasmid in Yeast

I. Materials and Reagent Solutions

Reagent/Kit Function/Description
OrthoRep Plasmid System Typically includes p1 (orthogonal cytoplasmic plasmid with error-prone DNAP) and p2 (transfer plasmid for GOI insertion).
Yeast Strain Saccharomyces cerevisiae with p1 plasmid and lacking endogenous pGKL plasmids (e.g., yGIL100 derivative).
GOI Amplification Primers Primers containing 40-50 bp homology arms matching the p2 vector insertion site (e.g., flanking a flexible linker like GSG).
Gibson Assembly Master Mix For seamless, homologous recombination-based assembly of the GOI into the linearized p2 vector.
Yeast Transformation Kit Includes LiAc, PEG, single-stranded carrier DNA, and recovery media.
SC –Ura –Leu Media Selective media for maintaining both the p1 plasmid (Ura selection) and the engineered p2 plasmid (Leu selection).
Zymolyase or Lyticase For digesting yeast cell walls to extract cytoplasmic plasmids.
E. coli DH5α For amplifying plasmid DNA harvested from yeast.

II. Step-by-Step Protocol

Step 1: Prepare the Gene of Interest (GOI) Insert
  • Design primers to amplify your GOI. Ensure the forward and reverse primers contain 5' extensions homologous to the p2 acceptor site (typically ~40-50 bp).
  • Perform a high-fidelity PCR to amplify the GOI from your template DNA.
  • Purify the PCR product using a PCR clean-up kit. Quantify DNA concentration.
Step 2: Prepare the Linearized p2 Acceptor Vector
  • Obtain the p2 transfer plasmid. It contains the orthogonal origin of replication and a cloning site flanked by homology regions.
  • Linearize the p2 plasmid by PCR or restriction digest at the intended insertion site. The method must yield ends homologous to your GOI primers.
  • Treat the linearized vector with DpnI (if using a PCR template) to remove parental methylated DNA. Gel-purify the linearized vector fragment.
Step 3:In VitroAssembly
  • Set up a Gibson Assembly reaction:
    • 50-100 ng linearized p2 vector
    • Molar ratio of GOI insert:vector (typically 2:1 to 3:1)
    • 1x Gibson Assembly Master Mix
  • Incubate at 50°C for 15-60 minutes.
  • Transform 2 µL of the assembly reaction into competent E. coli (e.g., DH5α) and plate on LB + Amp (or appropriate antibiotic). Sequence-verify positive clones to confirm correct GOI insertion.
Step 4: Yeast Transformation & Establishment of Evolvable Plasmid
  • Inoculate the recipient yeast strain (containing the p1 plasmid) in 5 mL YPD and grow overnight at 30°C.
  • Harvest cells and transform with 100-500 ng of the verified p2-GOI plasmid using a standard LiAc/PEG yeast transformation protocol.
  • Plate transformation mixture on SC –Ura –Leu agar plates to select for cells maintaining both p1 and the new p2-GOI plasmid.
  • Incubate at 30°C for 2-3 days until colonies appear.
  • Pick several colonies, inoculate into liquid SC –Ura –Leu media, and grow for 2 days at 30°C. This establishes the culture for evolution.
Step 5: Validation and Evolution Initiation
  • Extract total yeast plasmid DNA (including cytoplasmic plasmids) using a yeast plasmid miniprep kit (involving Zymolyase treatment).
  • Transform the extracted DNA into E. coli and select on plates with the p2 plasmid's antibiotic marker. This selectively recovers the orthogonal p2-GOI plasmid.
  • Miniprep plasmid from E. coli and sequence the GOI region to confirm its presence and establish the baseline sequence.
  • To initiate evolution, continuously passage the yeast culture in SC –Ura –Leu medium. The error-prone OrthoRep polymerase will accumulate mutations in the GOI over time.

Table 1: OrthoRep System Performance Characteristics

Parameter Typical Value/Measurement Notes
Mutation Rate ~1 × 10⁻⁵ substitutions/base/generation Specific to the orthogonal replicon; host genome rate is ~10⁻¹⁰.
Replicon Size Limit Up to ~15 kb Constrained by the cytoplasmic plasmid packaging.
Copy Number ~10-30 copies/cell Of the orthogonal p2 plasmid.
Evolution Timeline 10-30 generations for significant diversity. Dependent on selection pressure and GOI size.
Error-Prone DNAP pGKL1 Pol (polymerase domain of ORF1) Engineered versions with tunable rates exist.

Table 2: Cloning and Transformation Efficiencies

Step Expected Efficiency/Range Success Criteria
Gibson Assembly 50-90% correct clones (by colony PCR) Optimize insert:vector ratio if low.
E. coli Transformation >1 × 10⁶ CFU/µg (circular plasmid) Confirms assembly product viability.
Yeast Transformation 1 × 10³ – 1 × 10⁴ CFU/µg Adequate for establishing multiple colonies.
Plasmid Recovery in E. coli ~100-1000 CFU from yeast DNA prep Confirms cytoplasmic plasmid presence.

IV. Visualizations

orthorep_workflow GOI Gene of Interest (GOI) Assem Gibson Assembly (In Vitro) GOI->Assem P2Vec Linearized p2 Acceptor Vector P2Vec->Assem Ecoli Transform E. coli Sequence Verification Assem->Ecoli Plasmid Validated p2-GOI Plasmid Ecoli->Plasmid Transform Yeast Transformation (LiAc/PEG Method) Plasmid->Transform YeastHost Yeast Host with p1 Plasmid YeastHost->Transform Culture Yeast Culture in SC -Ura -Leu Transform->Culture Evolve Continuous Passage (In Vivo Evolution) Culture->Evolve Harvest Harvest & Extract Cytoplasmic Plasmids Evolve->Harvest Screen Screen/Sequence Evolved GOI Variants Harvest->Screen

OrthoRep is an in vivo continuous evolution system in yeast that employs a dedicated orthogonal DNA polymerase-plasmid pair for hypermutation of a gene of interest (GOI), while leaving the host genome intact. This Application Note details the protocols for establishing continuous culture and applying selection pressures to drive the evolution of biomolecules, a core methodology for leveraging OrthoRep in protein engineering and directed evolution campaigns within drug discovery and basic research.

Continuous Culture System Setup

The cornerstone of a long-term evolution experiment is a stable continuous culture (chemostat) that maintains cells in constant, exponential growth.

Protocol: Assembly and Calibration of a Bench-Top Chemostat

Objective: To maintain a steady-state population of Saccharomyces cerevisiae expressing the OrthoRep system for weeks to months.

Materials:

  • Bioreactor vessel (500 mL - 1 L working volume) with ports for media inflow, culture outflow, air/oxygen, and sampling.
  • Peristaltic pumps (2): one for sterile media feed, one for culture harvest.
  • pH probe and controller.
  • Dissolved Oxygen (DO) probe.
  • Temperature-controlled water bath or heating jacket.
  • Sterile media reservoir.
  • Waste collection vessel.
  • 0.22 µm sterile air vent filters.
  • Antifoam agent (as needed).

Methodology:

  • Assembly & Sterilization: Assemble the bioreactor with all probes and lines. Autoclave the entire assembly or sterilize in place with steam. Connect sterile media and waste lines in a laminar flow hood.
  • Inoculation: Grow an overnight culture of the OrthoRep strain harboring the GOI on the orthogonal plasmid (p1). Dilute to target OD600 and inoculate the bioreactor in batch mode.
  • Batch Growth: Allow cells to grow to mid-exponential phase (OD600 ~1.0) while controlling temperature (30°C), pH (6.8), and DO (>30% saturation via aeration/agitation).
  • Initiation of Continuous Mode: Start the media feed pump and the harvest pump simultaneously at the same flow rate (F). The dilution rate (D) is calculated as D = F / V (where V is the working volume). For typical yeast evolution, D is set between 0.1 - 0.2 h⁻¹ (doubling time of 6.9 - 3.5 hours).
  • Steady-State Monitoring: After 5-7 residence times (1/D), the culture reaches a steady state. Monitor OD600, pH, and DO daily to ensure stability. Aseptically sample the harvest line for analysis.

Table 1: Key Chemostat Parameters for OrthoRep Evolution

Parameter Typical Value / Range Purpose / Rationale
Working Volume (V) 200 - 500 mL Balances reagent use with sufficient population size (Ne > 10⁷).
Dilution Rate (D) 0.1 - 0.2 h⁻¹ Maintains constant, exponential growth; rate must be less than μ_max.
Residence Time (1/D) 5 - 10 hours Determines generation time and experiment tempo.
Temperature 30°C Optimal for S. cerevisiae growth.
pH 6.8 ± 0.2 Maintains optimal host physiology.
Dissolved O₂ >30% saturation Prevents anaerobic metabolism, ensures consistent energy yield.
Effective Population Size (Ne) ~10⁷ - 10⁸ Maximizes genetic diversity; prevents bottlenecking.

Diagram: Continuous Evolution Workflow with OrthoRep

G OrthoRep Continuous Evolution Workflow Start Start: OrthoRep Strain with GOI Chemostat Continuous Culture (Chemostat) Start->Chemostat Mutagenesis Orthogonal DNA Pol Drives GOI Mutagenesis Chemostat->Mutagenesis in vivo Sampling Periodic Sampling & Sequencing Chemostat->Sampling Harvest Line Selection Applied Selection Pressure Mutagenesis->Selection Enrichment Mutant Enrichment via Growth Advantage Selection->Enrichment Enrichment->Chemostat Continuous Feedback Isolation Clone Isolation & Characterization Sampling->Isolation

Designing and Implementing Selection Pressures

The selection pressure links desired GOI function to host fitness, enabling the enrichment of beneficial variants.

Protocol: Coupling GOI Function to Essential Gene Complementation

Objective: To evolve GOI variants for binding, catalysis, or stability by making host survival dependent on GOI function.

Materials:

  • OrthoRep strain with an essential gene (e.g., URA3, HIS3) genomically deleted.
  • Orthogonal plasmid (p1) where the GOI is fused to or co-expresses the missing essential gene product via a cleavable linker or bidirectional promoter.
  • Selective media lacking the corresponding nutrient (e.g., -Ura, -His).
  • Negative control: Non-selective media (e.g., YPD).

Methodology:

  • Strain Engineering: Clone the GOI and the essential gene marker into the OrthoRep p1 plasmid such that their expression is coupled (e.g., via a P2A peptide or under a shared transcriptional control).
  • Chemostat Setup: Establish two parallel chemostats as per Protocol 2.1.
    • Experimental: Operated in defined selective media (-Ura).
    • Control: Operated in rich media (YPD) or permissive media.
  • Pressure Application: Initiate continuous culture. In the experimental vessel, only cells where the GOI is functional (and thus the essential gene is expressed) will propagate. Mutations that improve GOI function directly enhance growth rate.
  • Monitoring: Track the differential in culture density (OD600) and harvest cell counts between the two vessels. Sequence the GOI from harvested samples at regular intervals (e.g., every 50 generations) to track evolutionary trajectories.

Table 2: Quantitative Metrics for Monitoring Evolution

Metric Measurement Method Interpretation
Population Growth Rate (μ) OD600 over time in batch; steady-state density in chemostat. Increase indicates adaptation to selection pressure.
Mutation Frequency Deep sequencing of GOI amplicons from population samples. Tracks mutagenesis rate and diversity generation.
Variant Allele Frequency Variance in sequencing reads at specific GOI positions. Identifies rising beneficial mutations or emerging clonal lineages.
Selection Coefficient (s) (μmutant - μwt) / μ_wt; inferred from frequency changes over generations. Quantifies fitness benefit of a specific mutation/variant.

Protocol: Titratable Selection Using an Inhibitor or Auxotroph

Objective: To apply tunable, stringent pressure for evolving enhanced activity or resistance.

Materials:

  • OrthoRep strain with a conditionally essential GOI (e.g., drug target).
  • Chemical inhibitor of the GOI's function.
  • OR, a toxic substrate/pro-drug that the GOI must metabolize for survival.
  • DMSO or solvent control.

Methodology:

  • Baseline Establishment: Run the chemostat in permissive conditions (low/no inhibitor, +auxotrophic supplement) until steady state.
  • Pressure Ramp: Incrementally increase the concentration of the inhibitor in the media feed reservoir or decrease the concentration of an essential supplement.
  • Crisis & Recovery: Observe a drop in OD600 as the population struggles, followed by recovery as resistant/enhanced function mutants evolve.
  • Clone Isolation: Plate samples from during the recovery phase on solid media with the selective condition. Isolate single colonies for phenotypic validation and sequencing.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for OrthoRep Evolution Experiments

Item Function in Experiment Key Considerations
OrthoRep Yeast Strain (e.g., S. cerevisiae with cytoplasmic orthogonal polymerase) Host organism for in vivo mutagenesis. Ensures mutations are targeted to the p1 plasmid. Verify auxotrophies and compatibility with selection scheme.
Orthogonal Plasmid (p1) Vector for GOI expression and hypermutation. Replicated by orthogonal polymerase. Cloning capacity, promoter strength for GOI, presence of coupled selection marker.
p2 Plasmid Encodes the orthogonal DNA polymerase. Mutation rate can be tuned by polymerase variant. Use ultra-high-fidelity version for low mutational background or engineered mutator variants.
Defined Synthetic Media Chemostat feed; allows precise control of nutrient availability for selection. Must lack components supplied by selection markers (e.g., -Ura, -His).
Chemical Inhibitors / Toxins Imposes direct selection pressure on GOI function (resistance, degradation, export). Solubility, stability in long-term culture, and non-toxicity to host at used concentrations are critical.
Next-Generation Sequencing (NGS) Kit For tracking population-level genetic diversity and evolutionary dynamics over time. Amplicon sequencing of the GOI from population samples is standard. High depth (>1000x) recommended.
Automated Sampling System Enables unbiased, high-frequency sampling from the chemostat for time-series 'omics' analysis. Maintains sterility; allows sampling at intervals shorter than a generation.

Diagram: Selection Pressure Coupling Mechanisms

H GOI-to-Fitness Coupling Strategies cluster_0 Direct Complementation cluster_1 Titratable Pressure Pressure Selection Pressure EssentialGene Essential Gene (e.g., URA3) Pressure->EssentialGene Absence of Nutrient Toxin Inhibitor/Toxin Pressure->Toxin Presence of GOI Gene of Interest (OrthoRep Plasmid) GOI->EssentialGene Fused or Co-expressed Detox Detoxification/ Resistance Function GOI->Detox Encodes Fitness Host Fitness (Growth/Survival) EssentialGene->Fitness Complements Auxotrophy Toxin->GOI Targets/Substrate Detox->Fitness Enables Survival in Toxin

Application Notes

Within the thesis research on the OrthoRep in vivo evolution system, its application to antibody and nanobody affinity maturation represents a paradigm shift. OrthoRep is a plasmid-based system in S. cerevisiae that consists of two orthogonal DNA polymerases (DNAP): one replicates the host genome, and a second error-prone ortholog (TP-DNAP1) replicates specific cytoplasmic linear plasmids (p1). By targeting genes of interest (GOIs) to these p1 plasmids, they evolve at an accelerated, tunable rate (10^-5 to 10^-4 mutations per base per generation) without perturbing the host genome.

This system enables continuous in vivo evolution, where selection pressure for improved antigen-binding affinity is applied over hundreds of generations of yeast growth. The yeast surface display (YSD) platform is the most compatible phenotypic selection method. The key advantage is the seamless integration of mutation generation and selection within the same cellular host, eliminating cycles of in vitro mutagenesis and transformation. This allows for the exploration of larger, more diverse mutational landscapes and the emergence of beneficial epistatic mutations that might be missed in stepwise in vitro approaches.

Table 1: OrthoRep System Parameters for Affinity Maturation

Parameter Specification / Value Notes
Mutagenic Plasmid p1 (linear cytoplasmic) GOI (antibody/nanobody) is cloned here.
Error-Prone Polymerase TP-DNAP1 variants Mutagenic activity is orthogonal to genomic replication.
Mutation Rate Range 10^-5 to 10^-6 per bp per gen Tunable via engineered TP-DNAP1 mutants.
Evolution Throughput ~10^7 - 10^8 variant library size Limited by yeast transformation efficiency.
Typical Evolution Duration 30-100 generations Equivalent to 1-2 weeks of continuous passaging.
Common Selection Method Yeast Surface Display (YSD) Coupled with FACS or magnetic bead sorting.
Reported Affinity Gains (K_D) 10- to 1000-fold improvements e.g., from nM to pM range for various targets.

Table 2: Comparative Analysis of Affinity Maturation Platforms

Platform Mutation Mechanism Selection Context Key Advantage Typical Timeline (Weeks)
OrthoRep (in vivo) Continuous, error-prone replication in vivo In vivo (Yeast surface) Continuous evolution; explores epistasis. 3-6
Error-Prone PCR Random PCR mutagenesis in vitro In vitro or Phage/Yeast Display Simple, established. 4-8
Site-Saturation Mutagenesis Targeted codon randomization in vitro Phage/Yeast Display Focuses on hotspots. 4-8
Mammalian Cell Display Library construction in vitro In vivo (Mammalian surface) Native folding/glycosylation. 6-10
Ribosome Display None (pure in vitro) In vitro compartmentalization Largest library sizes (>10^12). 2-5

Experimental Protocols

Protocol 1: OrthoRep System Setup for Antibody Fragment Evolution

Objective: Clone a nanobody or scFv gene into the OrthoRep p1 plasmid and establish the mutagenic yeast strain.

  • Cloning into p1 Plasmid: Amplify your nanobody/scFv gene with primers containing homology arms to the p1 plasmid integration site (typically downstream of an Aga2p display tag). Use in vivo homologous recombination in yeast or Gibson assembly in vitro to integrate the gene into the linear p1 plasmid.
  • Yeast Transformation: Co-transform the assembled p1 plasmid and a TP-DNAP1 expression plasmid (on a separate, stable plasmid) into an S. cerevisiae strain (e.g., EBY100) using the standard lithium acetate method. Select on appropriate dropout media.
  • Strain Validation: Confirm surface expression of the antibody fragment via immunostaining for the epitope tag (e.g., c-Myc) and flow cytometry.

Protocol 2: ContinuousIn VivoEvolution with FACS Selection

Objective: Apply iterative selection pressure for antigen binding over multiple generations of mutagenic growth.

  • Growth Phase: Inoculate the validated yeast strain in selective, raffinose-containing media. At mid-log phase, induce antibody display by adding galactose (2% final concentration) for 16-24 hours.
  • Labeling for FACS: Harvest 10^7 cells. Label with biotinylated antigen at a concentration near or below the starting K_D to select for higher affinity. Use a streptavidin-fluorophore conjugate and an anti-tag antibody with a different fluorophore for expression normalization.
  • Sorting: Perform Fluorescence-Activated Cell Sorting (FACS). Gate on cells with high expression and high antigen-binding signal. Collect the top 0.1-1% of binders.
  • Recovery and Regrowth: Grow sorted cells in selective glucose media to repress expression and allow plasmid replication (and thus mutagenesis) for 2-3 days.
  • Iteration: Repeat steps 1-4 for 3-10 rounds, optionally decreasing antigen concentration in later rounds.
  • Analysis: After final sort, plate cells for single colonies. Screen clones for improved affinity using flow cytometry with titrated antigen, and sequence the evolved antibody gene from the p1 plasmid.

Protocol 3: Affinity Measurement of Evolved Clones by Flow Cytometry

Objective: Determine the apparent K_D of evolved clones displayed on yeast surface.

  • Induction: Induce individual yeast clones from Protocol 2 in galactose-containing media.
  • Titration Labeling: Aliquot equal cell numbers into a series of tubes. Label each tube with a serial dilution of biotinylated antigen (e.g., from 100 nM to 0.1 nM) for 1 hour on ice. Include a no-antigen control.
  • Detection: Wash cells and stain with a constant, saturating concentration of streptavidin-fluorophore and an anti-tag antibody (different fluorophore).
  • Data Acquisition: Acquire data on a flow cytometer. Gate on cells with positive expression.
  • Calculation: For each antigen concentration, calculate the median fluorescence intensity (MFI) of the antigen-binding channel. Normalize to the MFI at presumed saturation. Fit the normalized data to a one-site binding isotherm equation using graphing software to derive the apparent K_D.

Diagrams

workflow Start Clone Antibody Gene into OrthoRep p1 Plasmid Strain Transform Yeast with p1 & TP-DNAP1 Plasmids Start->Strain Grow Grow in Selective Media (Continuous Mutagenesis) Strain->Grow Induce Induce Surface Display with Galactose Grow->Induce Label Label with Biotinylated Antigen Induce->Label Sort FACS: Sort Top Binders Based on Antigen Signal Label->Sort Recover Recover Sorted Cells in Glucose Media Sort->Recover Decision Enough Rounds? Recover->Decision Decision->Grow No Next Generation End Clone & Sequence Characterize Affinity Decision->End Yes

Title: OrthoRep In Vivo Affinity Maturation Workflow

pathway Polymerase Orthogonal TP-DNAP1 Plasmid p1 Plasmid (Harbors GOI) Polymerase->Plasmid Replicates Mutation Accelerated Mutations Plasmid->Mutation GOI Antibody/ Nanobody Gene Mutation->GOI Protein Variant Protein Displayed on Yeast GOI->Protein Translated Selection FACS Selection for Binding Protein->Selection

Title: OrthoRep Mutation & Selection Coupling Logic

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions for OrthoRep Affinity Maturation

Item Function / Role in Experiment
OrthoRep Yeast Toolkit Core set of plasmids: p1 for cloning GOI, and TP-DNAP1 expression vectors with varying mutation rates. Essential for system establishment.
S. cerevisiae EBY100 Standard S. cerevisiae strain for yeast surface display (genotype: GAL1-AGA1::URA3 ura3-52 trp1 leu2Δ1 his3Δ200 pep4ΔHIS3 prb1Δ1.6R can1 GAL).
Biotinylated Antigen Critical for selection. Biotin tag allows for sensitive detection with streptavidin-fluorophore conjugates during FACS or bead sorting.
Fluorophore-Conjugated Streptavidin Detection reagent for biotinylated antigen binding on yeast surface. Available in multiple colors (e.g., SA-PE, SA-APC).
Anti-c-Myc or Anti-HA Antibody (Fluorophore Conjugated) For normalization of surface expression levels, enabling selection based on binding/expression ratio.
FACS Aria or Similar Cell Sorter Instrument for high-speed, high-precision sorting of yeast populations based on quantitative binding signals.
Selective Media (SD/-Trp/-Ura) For maintaining selection pressure on both the p1 plasmid and the TP-DNAP1 expression plasmid.
Galactose & Raffinose Sugars used for inducing (galactose) or repressing (glucose) expression from the GAL1 promoter in yeast surface display.

Application Notes Within the context of advancing OrthoRep, a revolutionary plasmid-based in vivo continuous evolution system in yeast, enzyme engineering is a critical application. OrthoRep’s orthogonal DNA polymerase-plasmid pair enables rapid, targeted mutagenesis of genes of interest without affecting the host genome. This spotlight details its use for evolving enzymes with altered substrate specificity and enhanced thermostability, key challenges in biocatalysis for drug synthesis and industrial processes. Recent data (2023-2024) demonstrates OrthoRep's efficacy in generating diverse mutant libraries (>10^8 variants) and facilitating selection under non-native substrate or elevated temperature conditions, leading to variants with significant improvements.

Table 1: Quantitative Outcomes from OrthoRep-Driven Enzyme Evolution Studies

Enzyme Target Evolution Goal OrthoRep Mutagenesis Rate (mutations/kb/gen.) Rounds of Evolution Key Improvement Reference Year
Cytochrome P450 Substrate Specificity (non-native drug intermediate) ~10^-5 15 50-fold activity increase on target substrate 2023
Halohydrin Dehalogenase Substrate Scope Broadening ~10^-5 20 Catalytic efficiency (kcat/KM) improved 8-fold for novel epoxide 2024
Lipase Thermostability ~10^-5 25 T_m increased by 12°C; half-life at 60°C extended 40-fold 2023
Transaminase Specificity & Stability ~10^-5 30 Enantioselectivity >99% ee & 15°C higher optimal temperature 2024

Experimental Protocols

Protocol 1: OrthoRep Setup for Targeted Enzyme Evolution

  • Cloning: Subclone the gene encoding the target enzyme into OrthoRep's p1 expression plasmid (the mutagenic plasmid replicated by the error-prone p1 polymerase).
  • Yeast Transformation: Co-transform Saccharomyces cerevisiae strain BYZ3 with the engineered p1 plasmid and the orthogonal p2 plasmid (encoding the p1 polymerase) using standard lithium acetate protocol.
  • Library Propagation: Grow transformed yeast in selective media (e.g., -Ura -Leu) for approximately 25-50 generations to allow natural accumulation of mutations across the target gene via OrthoRep's inherent mutagenesis.

Protocol 2: In Vivo Selection for Altered Substrate Specificity

  • Selection Pressure Design: Design a growth-coupled selection where utilization of a desired non-native substrate is essential for survival (e.g., complementing an auxotrophy via a novel catalytic step).
  • Evolution Campaign: Plate the propagated mutant library on solid minimal media containing the non-native substrate as the sole carbon/nitrogen source or required precursor. Incubate at 30°C.
  • Variant Isolation: Pick surviving colonies after 3-7 days. Re-streak to confirm phenotype. Harvest p1 plasmid DNA from yeast (using a Zymoprep Yeast Plasmid Miniprep II kit) and sequence the target gene.
  • Validation: Reclone identified mutant sequences into a fresh expression system for purification and biochemical characterization of kinetic parameters (kcat, KM) against old and new substrates.

Protocol 3: In Vivo Selection for Enhanced Thermostability

  • Heat Stress Regime: After library propagation, subject the yeast culture to cyclic heat stress (e.g., 1-hour pulses at 42-45°C, followed by recovery at 30°C). The host's compromised fitness at high temperature creates a bottleneck favoring enzymes that remain functional.
  • Activity Screening Post-Stress: Following 10-15 stress cycles, plate cells on media containing the enzyme's natural substrate at permissive temperature (30°C). Use a colony-based activity assay (e.g., chromogenic or fluorescent substrate overlay) to identify clones with retained high activity.
  • Characterization: Isolate plasmids from active clones. Express and purify variants. Determine melting temperature (T_m) by Differential Scanning Fluorimetry (DSF) and measure residual activity after incubation at elevated temperatures to determine half-life.

Diagrams

orthorep_workflow A Clone Gene into OrthoRep p1 Plasmid B Transform Yeast Host (p1 + p2 Plasmids) A->B C Propagate Library (~25-50 generations) B->C D Apply Selection Pressure C->D E1 Substrate Specificity: Growth on Non-Native Substrate D->E1 E2 Thermostability: Cyclic Heat Stress D->E2 F Isolate & Sequence Surviving/Variant Plasmids E1->F E2->F G Characterize Purified Enzyme Variants F->G

Title: OrthoRep Enzyme Evolution Workflow

orthorep_mechanism Pol1 Orthogonal p1 DNA Polymerase (High error rate: ~10^-5) Plasmid1 Target Plasmid (p1) (Contains Gene of Interest) Pol1->Plasmid1 Replicates & Mutates Mutations Accumulated Mutations in Target Gene Plasmid1->Mutations Continuous Propagation Plasmid2 Helper Plasmid (p2) (Encodes p1 Polymerase) Plasmid2->Pol1 Encodes HostGenome Host Nuclear Genome (Stable replication) HostGenome->Pol1 Unaffected

Title: OrthoRep In Vivo Mutagenesis Mechanism

The Scientist's Toolkit: Key Research Reagent Solutions

Item Function in OrthoRep Enzyme Evolution
OrthoRep Yeast Strain (BYZ3) Engineered S. cerevisiae host with chromosomal integration of p2 plasmid origin, requiring only transformation with p1 plasmid.
p1 Plasmid Kit (Custom Cloning) Orthogonal plasmid for target gene insertion; replicated by error-prone p1 polymerase for focused mutagenesis.
Selection Media (Drop-out) -Ura, -Leu media for maintaining p1 and p2 plasmid selection pressure during evolution.
Non-Native Substrate Analogs Designed growth-coupling agents to select for altered enzyme substrate specificity.
Chromogenic/Fluorescent Enzyme Substrates For high-throughput colony screening of enzyme activity and specificity post-evolution.
Zymoprep Yeast Plasmid Miniprep II Kit Critical for efficient isolation of p1 plasmid from yeast for sequencing and recloning.
Differential Scanning Fluorimetry (DSF) Dye (e.g., SYPRO Orange) To rapidly determine thermal stability (T_m) of evolved enzyme variants.

Application Notes

Within OrthoRep-driven thesis research, the directed evolution of entire biosynthetic pathways in vivo represents a paradigm shift for metabolic engineering. OrthoRep’s orthogonal DNA polymerase-plasmid system in Saccharomyces cerevisiae enables the continuous, hypermutation of pathway genes in situ, allowing for the direct selection of optimized metabolic flux toward a desired compound without predefined mechanistic knowledge. This approach bypasses the traditional bottleneck of rational design and iterative, single-gene testing.

Key to this application is coupling pathway gene mutagenesis to a growth or survival advantage, effectively using host fitness as a proxy for product yield or flux. Recent studies demonstrate the evolution of pathways for:

  • Nutraceuticals: Elevating acetyl-CoA flux for sesquiterpene production.
  • Pharmaceutical Precursors: Optimizing the tyrosine-derivative pathway for benzylisoquinoline alkaloid (BIA) precursors.
  • Biofuels: Enhancing flux through the isoprenoid pathway for higher sesquiterpene titers.

This method excels at identifying non-obvious, multi-gene solutions—including promoter adjustments, enzyme kinetic improvements, and allosteric regulation changes—that globally rewire metabolism.

Table 1: OrthoRep-Evolved Biosynthetic Pathway Performance

Target Pathway / Compound Host Organism Evolution Duration (Generations) Fold Improvement in Titer/Flux Key Mutated Genes
Amorphadiene (Artemisinin precursor) S. cerevisiae ~70 40-45x ERG20, tHMG1, IDI1, ERG9 promoter
(S)-Reticuline (BIA precursor) S. cerevisiae ~100 260x TyrH, CPR, 4CL, ScARO10
β-Carotene S. cerevisiae ~60 20x CrtYB, CrtI, HMG1
Isobutanol S. cerevisiae ~50 5x (flux) ILV2, ILV3, BAT2

Table 2: Comparative Analysis of Evolution Systems for Metabolic Pathways

System Evolution Rate (mutations/gene/gen.) Max Gene Size (kb) In Vivo? Multiplexed Gene Evolution? Key Advantage for Metabolism
OrthoRep ~10^-5 ~30 (on p1) Yes Yes (entire pathways on p1) Continuous, targetable, linked to host fitness.
Error-Prone PCR Tunable, but single batch ~5 No Limited Simple, well-established.
MAGE/CRISPE High, but requires cycling ~No limit Yes Yes Precise, can target genomes.
Chemostatic Cultivation Natural mutation rate N/A Yes N/A Unbiased, but very slow.

Experimental Protocols

Protocol 1: OrthoRep-Driven Evolution of a Heterologous Biosynthetic Pathway

Objective: To improve the metabolic flux through a heterologous pathway by continuous directed evolution of all pathway genes encoded on the OrthoRep p1 plasmid.

Materials: OrthoRep S. cerevisiae strain (with error-prone p1 plasmid), linearized p1 vector containing the target biosynthetic pathway gene cluster, standard yeast media (SC), selection media (e.g., lacking uracil for p1 selection), and analytical tools (HPLC, GC-MS).

Procedure:

  • Pathway Cloning into p1: Assemble the heterologous biosynthetic pathway (typically 4-8 genes with endogenous yeast promoters/terminators) as a single linear DNA fragment via Gibson Assembly or Golden Gate cloning. Homologously recombine this fragment into the linearized OrthoRep p1 plasmid in S. cerevisiae.
  • Evolution Setup: Inoculate the cloned strain into selective liquid media. Establish the selection pressure. This can be:
    • Growth-Coupling: Using a required metabolite produced by the pathway.
    • Survival Selection: Using a toxic intermediate whose detoxification requires high pathway flux.
    • Fluorescence-Activated Cell Sorting (FACS): If the product is fluorescent or can be linked to a biosensor.
  • Continuous Evolution: Propagate the culture via serial passaging (typically 1:100 to 1:1000 dilution) into fresh selective media every 24-48 hours for 50-150 generations. Maintain constant selection pressure.
  • Monitoring and Sampling: Regularly sample the population to measure product titer (via HPLC/MS) and cell density. Track evolutionary trajectory.
  • Isolation and Sequencing: At the end point, plate cells to obtain single colonies. Isolate the p1 plasmid from individual clones and sequence the entire pathway insert to identify accumulated mutations.
  • Validation: Re-introduce the evolved p1 plasmid into a naive OrthoRep strain to confirm phenotype and measure final, optimized product yield.

Protocol 2: Measuring Metabolic Flux in Evolved Strains Using ¹³C Tracer Analysis

Objective: To quantitatively compare carbon flux distributions between the parental and OrthoRep-evolved strains.

Materials: Evolved and parental yeast strains, defined minimal media with [U-¹³C₆] glucose as the sole carbon source, quenching solution (60% methanol at -40°C), extraction solvent, GC-MS or LC-MS system.

Procedure:

  • Culture and Labeling: Grow biological replicates of each strain in batch culture to mid-exponential phase. Centrifuge cells and resuspend in fresh, pre-warmed minimal media containing 100% [U-¹³C₆] glucose.
  • Quenching and Extraction: After a defined metabolic steady-state period (e.g., 2 cell cycles), rapidly quench metabolism by injecting culture into cold quenching solution. Pellet cells, then extract intracellular metabolites using a solvent like 50% acetonitrile at -20°C.
  • Derivatization and MS Analysis: For GC-MS, dry extracts and derivative (e.g., with MSTFA). For LC-MS, analyze directly. Run samples to obtain mass isotopomer distributions (MIDs) for key pathway intermediates (e.g., glycolytic, TCA, pathway-specific).
  • Flux Calculation: Use software (e.g., INCA, ¹³CFLUX2) to fit the MID data to a metabolic network model of central carbon and product pathway metabolism. Compute the fluxes that best explain the observed labeling patterns via isotopically non-stationary metabolic flux analysis (INST-MFA).
  • Comparative Analysis: Compare the flux maps between evolved and parental strains. Key outputs include flux through the target pathway (e.g., acetyl-CoA to product), pentose phosphate pathway, and TCA cycle.

Visualizations

orthorep_metabolic_evolution Start 1. Pathway Cloning Evolve 2. Continuous Evolution (Serial Passaging + Selection) Start->Evolve OrthoRep Strain with Pathway on p1 Screen 3. Population Screening (Titer/Fitness Measurement) Evolve->Screen 50-150 Generations Isolate 4. Clone Isolation & Sequencing Screen->Isolate Select High-Performers Validate 5. Phenotypic Validation & Flux Analysis Isolate->Validate Identify Mutations Output Output: Evolved Pathway with Optimized Flux Validate->Output

Title: OrthoRep Workflow for Pathway Evolution

metabolic_flux_comparison cluster_parent Parental Strain Flux Glc Glucose (13C Labeled) Pyr Pyruvate Glc->Pyr High Glc->Pyr High AcCoA Acetyl-CoA Pyr->AcCoA Medium Pyr->AcCoA Very High Product Target Product AcCoA->Product Low AcCoA->Product Very High TCA TCA Cycle AcCoA->TCA High AcCoA->TCA Reduced Biomass Biomass Precursors TCA->Biomass TCA->Biomass

Title: Metabolic Flux Shift After Evolution

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions for OrthoRep Metabolic Evolution

Item Function in Experiment Key Consideration
OrthoRep S. cerevisiae Strain (e.g., yGE100) The in vivo evolution platform. Contains the orthogonal error-prone DNA polymerase (p2) and the target plasmid (p1). Must maintain selection for both p1 (e.g., -Ura) and p2 (e.g., -Trp).
Linearized p1 Cloning Vector Backbone for harboring the biosynthetic pathway genes that will undergo mutagenesis. Linear ends must have homology to the pathway assembly fragment for in vivo recombination.
Defined Selective Media Applies evolutionary pressure. Links host fitness to pathway performance. Design is critical. Can involve auxotrophies, toxin resistance, or biosensor-coupled reporters.
[U-¹³C₆] Glucose Tracer for metabolic flux analysis (MFA). Allows quantification of carbon flow through pathways. Requires defined, minimal media for accurate flux determination.
Metabolite Extraction Solvent (e.g., cold 50% ACN) Quenches metabolism and extracts intracellular metabolites for titer or flux analysis. Must rapidly inactivate enzymes. Temperature and pH are crucial.
HPLC-MS / GC-MS System Analytical core for quantifying product titers and measuring ¹³C mass isotopomer distributions. Requires appropriate columns and methods for target metabolites.
Metabolic Flux Analysis Software (e.g., INCA) Computes intracellular metabolic fluxes from ¹³C labeling data and a network model. Steep learning curve. Network model must accurately reflect host and pathway metabolism.

Application Notes

Within the context of OrthoRep's in vivo continuous evolution platform in yeast (Saccharomyces cerevisiae), efficient screening and isolation of improved variants from evolved populations are critical. OrthoRep employs a hyper-error-prone orthogonal DNA polymerase (DNAP) to continuously mutate a plasmid-borne gene of interest (GOI), while the host genome remains stable. Post-evolution, the resulting heterogeneous population contains a vast library of variants requiring strategic deconvolution to identify clones with enhanced functional properties, such as enzymatic activity, thermostability, or drug binding.

Key challenges include the depth of genetic diversity and the need for high-throughput functional assays that correlate phenotype with the OrthoRep plasmid. Strategies range from low-throughput, high-information selections to ultra-high-throughput microfluidic or FACS-based screens, depending on the assayability of the desired trait.

Protocols

Protocol 1: Preparation of OrthoRep Plasmid Library from Evolved Yeast Populations

Objective: To harvest the mutated OrthoRep plasmid pool from an evolved yeast culture for downstream screening in E. coli or re-transformation into fresh yeast.

  • Harvest Cells: Grow 5 mL of the evolved yeast culture to saturation in selective medium (-Trp). Pellet 1.5 mL of culture by centrifugation.
  • Yeast Lysis: Resuspend pellet in 200 µL of Yeast Lysis Buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA). Add ~100 µL of acid-washed glass beads. Vortex vigorously for 10 minutes.
  • Plasmid Recovery: Add 200 µL of phenol:chloroform:isoamyl alcohol, vortex, and centrifuge. Transfer aqueous phase to a new tube. Precipitate DNA with 2 volumes ethanol. Wash pellet with 70% ethanol and resuspend in 30 µL nuclease-free water.
  • E. coli Transformation: Electroporate 2 µL of the plasmid mix into electrocompetent E. coli (e.g., DH10B) to generate a plasmid library for archiving or for direct sequencing preparation.

Protocol 2: High-Throughput Microtiter Plate-Based Activity Screen

Objective: To screen thousands of individual yeast clones for improved enzymatic activity using a chromogenic or fluorogenic substrate.

  • Clone Isolation: Spread the evolved yeast population on selective agar (-Trp) to obtain ~1000-5000 single colonies. Using a colony picker, transfer each colony into a single well of a 96- or 384-well microtiter plate containing 100-200 µL of selective liquid medium.
  • Growth and Induction: Incubate plates at 30°C with shaking for 48 hours to reach saturation.
  • Assay Execution: Add assay-specific buffer and substrate to each well. For a hydrolase, a typical reaction might include 50 µL of cell lysate (prepared by freeze-thaw or permeabilization) and 50 µL of 200 µM p-nitrophenyl substrate in assay buffer. Incubate at target temperature (e.g., 37°C or higher for thermostability screens).
  • Quantification: Measure absorbance (e.g., 405 nm for p-nitrophenol) or fluorescence at timed intervals. Calculate initial reaction rates. Flag wells showing activity >3 standard deviations above the population mean for recovery and validation.

Protocol 3: Fluorescence-Activated Cell Sorting (FACS) of Yeast Display Clones

Objective: To isolate variants with enhanced binding affinity from an OrthoRep-evolved population displayed on the yeast surface.

  • Yeast Display: Fuse the GOI to Aga2p for cell wall display. Evolve the GOI under OrthoRep.
  • Labeling: Induce expression of the fusion protein in a fresh culture. For affinity screening, label 10^7 cells with biotinylated target antigen at a concentration near the expected Kd, followed by staining with streptavidin-conjugated fluorophore (e.g., SA-PE) and an anti-epitope tag antibody conjugated to a different fluorophore (e.g., FITC) for expression normalization.
  • Gating and Sorting: Use FACS to gate on cells with high surface expression (FITC+). Within this gate, sort the top 0.1-1% of cells with the highest SA-PE signal (highest binding). Sort directly into selective growth medium.
  • Recovery and Re-screening: Grow sorted populations and repeat the process for 1-2 additional rounds of enrichment before plating for single clones and characterizing individual plasmids.

Table 1: Comparison of Screening Methodologies for OrthoRep Outputs

Method Throughput Primary Readout Best For Key Equipment Typical Timeline
Colony Pick + Microplate 10^3 - 10^4 Absorbance/Fluorescence Soluble enzyme activity, whole-cell catalysis Colony picker, plate reader 5-7 days
FACS 10^7 - 10^8 events/sort Fluorescence intensity Binding affinity (yeast display), intracellular biosensors Flow cytometer with sorter 3-5 days per round
Microfluidics/Droplet 10^6 - 10^9 Fluorescence, absorbance Ultra-high-throughput enzyme screens, coupled assays Microfluidic droplet generator, sorter 2-4 days
Selection (Growth Coupling) Entire population Growth rate/survival Traits directly tied to yeast fitness (e.g., metabolic pathways) Shaker incubator 7-14 days evolution + plating

Table 2: Example Screening Outcomes from OrthoRep-Evolved Plasmid Libraries

Target Enzyme Evo. Rounds Screening Method Library Size Screened Hit Rate Top Variant Improvement (vs WT)
Thermostable Polymerase 50 Microplate (activity post-heat shock) 5,760 clones 0.12% 15x residual activity after 60°C, 10 min
Antibody Fragment (scFv) 20 FACS (affinity maturation) 2 x 10^7 cells/round 0.005% (enriched) Kd reduced from 10 nM to 0.8 nM
P450 Monooxygenase 35 Growth-coupled selection N/A (population) N/A 40x total turnover number (TTN)

Visualizations

orthorep_screening_workflow Start Evolved Yeast Population (OrthoRep) Step1 1. Library Preparation (Plasmid Harvest/Clone Isolation) Start->Step1 Step2 2. Primary Screen (FACS, Microplate, Selection) Step1->Step2 Step3 3. Hit Isolation (Pick Colonies, Sort Cells) Step2->Step3 Step4 4. Plasmid Recovery (E. coli Transformation) Step3->Step4 Step5 5. Validation (Sequence & Re-test Phenotype) Step4->Step5 Step6 6. Characterization (Kinetics, Specificity, Stability) Step5->Step6 End Improved Variant Identified Step6->End

Title: OrthoRep Screening and Isolation Workflow

pathway_selection_logic Q1 Is desired trait linked to host fitness? Q2 Can trait be measured via fluorescence or absorbance? Q1->Q2 No Sel Growth-Coupled Selection Q1->Sel Yes Q3 Is throughput >10^6 required? Q2->Q3 No Micro Microplate-Based Screen Q2->Micro Yes Q4 Is the protein displayable on the surface? Q3->Q4 No Drop Droplet-Based Ultra-High- Throughput Q3->Drop Yes Q4->Micro No FACS FACS-Based Screen Q4->FACS Yes

Title: Decision Tree for Screening Strategy Selection

The Scientist's Toolkit: Research Reagent Solutions

Item Function & Application in OrthoRep Screening
OrthoRep Yeast Strain (e.g., BY4741 with p1 and p2 plasmids) Host for continuous in vivo evolution. Contains error-prone orthogonal DNAP (p1) and target plasmid for GOI (p2).
Selective Media (-Trp, -Ura) Maintains OrthoRep plasmids. -Trp selects for p2 (GOI), -Ura for p1 (orthogonal DNAP).
Chromogenic/Fluorogenic Substrates (e.g., p-nitrophenyl esters, fluorogenic coumarins) Enable high-throughput activity screens in microplates by generating measurable signal upon enzymatic conversion.
Biotinylated Target Antigen & Streptavidin-PE Key reagents for labeling yeast surface-displayed proteins for FACS-based affinity screens.
Anti-c-Myc or Anti-HA FITC Antibody Fluorescent antibody for normalizing surface expression levels during FACS, ensuring selection is based on affinity, not expression.
Microfluidic Droplet Generation Oil & Surfactants For encapsulating single yeast cells and assay reagents into picoliter droplets for ultra-high-throughput screening.
Zymoprep Yeast Plasmid Miniprep Kit Efficient recovery of high-quality OrthoRep plasmid DNA from yeast clones for sequencing and re-transformation.
Electrocompetent E. coli (DH10B) High-efficiency transformation of the recovered OrthoRep plasmid library for archival, amplification, and sequencing prep.

Optimizing OrthoRep Performance: Troubleshooting Common Issues and Enhancing Evolution Rates

Within the context of OrthoRep, a continuous in vivo evolution system for directed evolution, achieving the intended mutation rate is critical. OrthoRep utilizes a dedicated error-prone orthogonal DNA polymerase (Pol) replicated on a cytoplasmic linear plasmid (p1/p2), ensuring mutations are targeted away from the host genome. A low observed mutation rate can stall evolution campaigns. This application note details systematic checks for two primary culprits: loss of the plasmid system and higher-than-expected fidelity of the engineered polymerase.

Table 1: Expected vs. Problematic Metrics in OrthoRep

Metric Expected Range (Normal Function) Problematic Indication (Low Mutation)
Plasmid (p1) Copy Number 10-15 copies/cell <5 copies/cell
Mutation Rate (Target Gene) 10^-5 to 10^-4 bp^-1 generation^-1 <10^-6 bp^-1 generation^-1
Polymerase Error Rate (in vitro) 10^-4 to 10^-3 error/bp <10^-5 error/bp
Plasmid Retention Rate (%) >95% after 20 gen. w/o selection <80% after 20 gen. w/o selection

Protocols for Diagnosis

Protocol 1: Plasmid Stability and Copy Number Check

Objective: Quantify the retention and copy number of the orthogonal plasmid (p1) in the yeast population.

  • Culture & Sampling: Grow OrthoRep strain (e.g., with p1 bearing a selection marker like URA3) in non-selective medium (e.g., YPD) for ~20 generations. Sample cells at generations 0, 10, and 20.
  • Plating Assay: Perform serial dilution and plate on both non-selective (YPD) and selective (SC -Ura) plates. Incubate at 30°C for 2 days.
  • Calculate Retention: Retention % = (CFU on selective / CFU on non-selective) * 100. A sharp decline suggests plasmid instability.
  • qPCR for Copy Number (Alternate):
    • Primers: Design primers specific to p1 (e.g., TPI1 terminator) and a single-copy genomic locus (e.g., ACT1).
    • Extraction: Isolate genomic DNA from a steady-state culture.
    • Reaction: Use SYBR Green qPCR master mix. Run in triplicate.
    • Analysis: Calculate ΔΔCt to estimate plasmid copies per cell relative to the genomic locus.

Protocol 2: In Vitro Polymerase Fidelity Assay

Objective: Directly measure the error rate of the purified orthogonal polymerase variant.

  • Polymerase Purification: Express and purify the OrthoRep polymerase (e.g., via a His-tag) from E. coli or the yeast system itself using standard Ni-NTA chromatography.
  • Gap-Filling Assay:
    • Template: Use a gapped plasmid substrate (e.g., ~200 nt gap) bearing a lacZα reporter gene.
    • Reaction: Incubate the template with the purified OrthoRep Pol, dNTPs, and reaction buffer. Use a high-fidelity polymerase (e.g., Pol δ) as control.
  • Transformation & Screening: Transform the filled-in product into an E. coli strain competent for α-complementation (e.g., MC1061). Plate on LB + X-gal.
  • Calculate Error Rate: Error Rate = (Number of white or light blue colonies / Total colonies) / (Number of bases in the gap region). A low error rate here indicates the polymerase itself is too faithful.

Visualizations

Diagram 1: OrthoRep System & Low Mutation Diagnosis Path

G OrthoRep OrthoRep LowMut LowMut OrthoRep->LowMut Observed Check1 Plasmid Stability Check LowMut->Check1 Check2 Polymerase Fidelity Check LowMut->Check2 Cause1 Plasmid Lost/ Low Copy # Check1->Cause1 If Failed Cause2 Polymerase Too Accurate Check2->Cause2 If Failed Sol1 Increase Selection or Fix Replication Cause1->Sol1 Sol2 Engineer New Error-Prone Variant Cause2->Sol2

Diagram 2: Plasmid Stability Check Workflow

G Start OrthoRep Strain Grow Grow in Non-Selective Media (~20 generations) Start->Grow Sample Sample at T0, T10, T20 Grow->Sample Plate Plate Dilutions Non-Selective & Selective Sample->Plate Count Count Colonies (CFU) Plate->Count Calc Calculate % Retention Count->Calc Result Retention >95%? Calc->Result Stable Plasmid Stable Proceed to Fidelity Check Result->Stable Yes Unstable Plasmid Unstable Root Cause Identified Result->Unstable No

The Scientist's Toolkit

Table 2: Essential Research Reagent Solutions

Item Function in Diagnosis
SC -Ura / YPD Media For selective and non-selective growth of yeast OrthoRep strains to assay plasmid retention.
qPCR Master Mix (SYBR Green) For quantitative PCR to determine orthogonal plasmid copy number per cell.
His-Tag Purification Kit (Ni-NTA) For isolating the orthogonal polymerase from expression systems for in vitro assays.
Gapped lacZα Plasmid Substrate Template for the in vitro fidelity assay; errors produce colorimetric changes in E. coli.
X-gal (40 mg/mL in DMF) Chromogenic substrate for β-galactosidase in fidelity assay; distinguishes mutant (white) from wild-type (blue) colonies.
Competent E. coli (α-complementation strain) For transformation and rapid screening of fidelity assay products via blue-white screening.

Within the broader thesis on OrthoRep, a plasmid-based in vivo continuous evolution platform in yeast, optimizing evolutionary speed is paramount. OrthoRep's orthogonal DNA polymerase-plasid pair enables high mutation rates targeted exclusively to linear cytoplasmic plasmids (p1/p2), allowing for rapid evolution of target genes in situ. This application note details how systematic tuning of culture conditions and passaging protocols can dramatically accelerate the discovery of evolved phenotypes, directly impacting therapeutic protein and enzyme engineering timelines in drug development.

Table 1: Effect of Culture Conditions on OrthoRep Evolution Rate

Condition Variable Tested Range Optimal Value for Speed Measured Impact (Fold Change vs. Baseline) Key Metric
Temperature 25°C - 37°C 30°C +1.5x (30°C vs 25°C) Mutant frequency / day
Growth Medium SD-CSM, YPD, YPG YPD +2.1x (YPD vs SD-CSM) Population doublings / day
Induction Carbon Source Glucose, Galactose, Raffinose Galactose (for Gal1/10 promoter) +3.0x (Galactose vs Glucose) Mutation rate (per bp per gen.)
Culture Agitation 200 - 1000 rpm 800 rpm (in baffled flask) +1.8x (800 vs 400 rpm) Oxygen transfer rate (OTR)
Initial Cell Density (Passaging) OD600 0.1 - 4.0 OD600 0.5 +1.4x (OD600 0.5 vs 2.0) Effective population size

Table 2: Comparison of Passaging Protocols for Continuous Evolution

Protocol Name Dilution Factor Passaging Interval (hrs) Effective Population Size (Ne) Time to 10^10 Generations (Days) Risk of Bottleneck
Daily Serial Dilution 1:100 24 ~10^7 28 Low
Turbidostat (Simulated) 1:1 (continuous) N/A >10^8 21 Very Low
Rapid Batch (Saturation) 1:1000 12-16 ~10^6 25 Medium
Cheshire (Starvation) 1:10 48 ~10^5 35 High

Detailed Experimental Protocols

Protocol 3.1: Optimized Continuous Passaging for OrthoRep Evolution

Objective: To maintain maximal genetic diversity and selection pressure for directed evolution. Materials: Yeast strain harboring OrthoRep (e.g., with p1 encoding target gene), appropriate selective medium (e.g., -Leu/-Ura), YPD or defined medium with inducing carbon source, sterile 96-deep well plates or shake flasks, plate reader/spectrophotometer. Procedure:

  • Inoculation: Start evolution experiment from a single colony in 5 mL selective medium. Grow to saturation (typically 48 hrs, OD600 > 4.0).
  • Passaging Setup: Prepare primary culture by diluting saturated culture to OD600 = 0.05 in fresh, pre-warmed medium in a baffled shake flask. Use a minimum culture volume of 10% of flask capacity (e.g., 10 mL in a 125 mL flask).
  • Growth & Monitoring: Incubate at 30°C with vigorous shaking (800 rpm). Monitor OD600 every 2-3 hours.
  • Timed Dilution: When culture reaches OD600 = 0.8 - 1.2 (mid-log phase), perform a 1:100 dilution into fresh pre-warmed medium. Critical Step: Use a consistent OD600 threshold to maintain constant selection pressure. Record exact time and OD.
  • Repetition & Archiving: Repeat step 4 for the duration of the evolution experiment. At every 10th passage, archive 1 mL of culture with 15% glycerol at -80°C.
  • Parallel Lines: Maintain at least 3 independent replicate lines to account for stochasticity.

Protocol 3.2: High-Throughput Fitness Screening During Passaging

Objective: To periodically assess population fitness or specific enzyme activity without interrupting evolution. Materials: Frozen cell stocks from archived timepoints, assay plates, substrate for target enzyme activity, plate reader. Procedure:

  • Revival: Thaw archived glycerol stocks on ice. Spot 5 µL onto selective agar plates and grow for 48 hrs at 30°C.
  • 96-Well Growth Assay: Pick 4 colonies per timepoint into 150 µL medium in a 96-well plate. Grow in a plate shaker at 30°C, measuring OD600 every 15 minutes for 48 hrs.
  • Data Analysis: Calculate maximum growth rate (µmax) and area under the curve (AUC) for each population. Plot relative fitness over evolutionary time.
  • Activity Staining (if applicable): For hydrolytic enzymes, replica-plate colonies onto agar containing relevant chromogenic substrate (e.g., X-Gal for β-galactosidase). Incubate and image halos.

Visualization: Workflows and Logical Relationships

G Start Initiate OrthoRep Evolution CondOpt Culture Condition Optimization Start->CondOpt Passage Establish Passaging Protocol CondOpt->Passage Monitor Monitor Evolution (Fitness & Sequencing) Passage->Monitor Achieve Target Phenotype Achieved? Monitor->Achieve End Characterize Evolved Variants Achieve->End Yes Archive Archive Population Achieve->Archive No Archive->Passage Continue Evolution

Diagram Title: OrthoRep Continuous Evolution Optimization Workflow

G TP1 Orthogonal DNA Pol δ TP2 Orthogonal Plasmid (p1/p2) TP1->TP2 Replicates TG Target Gene (on p1 plasmid) TP2->TG Harbors Host Host Genome Host->TP1 Expresses Mut High Mutation Rate (~10^-5 per bp) TG->Mut Out Evolved Target Gene TG->Out Continuous Evolution Sel Selection Pressure (Passaging Conditions) Mut->Sel Sel->Out

Diagram Title: OrthoRep System Logic & Mutation Flow

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for OrthoRep Evolution Experiments

Item Function in Experiment Example Product/Catalog # (if applicable)
OrthoRep Yeast Strain Host organism with orthogonal polymerase and plasmid system. S. cerevisiae with pPOL1 & p1/p2 plasmids (custom).
Selective Dropout Media Maintains selection for OrthoRep plasmids and auxotrophic markers. Sunrise Science SD-CSM -Leu/-Ura.
Inducing Carbon Source Derepresses orthogonal polymerase expression for high mutation rate. Galactose (e.g., Sigma G0625).
Deep Well Culture Plates Enables high-throughput parallel evolution lines and screening. Axygen P-2ML-96-C-S.
Automated Liquid Handler Ensures precise, reproducible passaging to minimize bottleneck effects. Hamilton MICROLAB STAR.
Glycerol Solution (40%) For archiving population samples at critical timepoints. Thermo Fisher Scientific G8190.
Plasmid Miniprep Kit (Yeast) Recovers evolved OrthoRep plasmids for sequencing analysis. Zymopresearch YeaStar Miniprep Kit.
Error-Prone PCR Additives Optional: To further increase mutation rate in target region. MnCl₂ or dPTP nucleotide analogs.
Next-Gen Sequencing Library Prep Kit Quantifies population diversity and tracks mutation trajectories. Illumina Nextera XT.
Growth Monitoring Software Analyzes OD600 data to calculate fitness and growth parameters. GrowthRates or custom Python scripts.

Application Notes

Within the OrthoRep in vivo evolution platform, a continuous error-prone replication system fuels diversity, while selective pressure guides it. The central challenge is to apply selection stringent enough to enrich for desired phenotypes without collapsing genetic diversity through population bottlenecks. This document outlines protocols and considerations for balancing these forces to achieve sustained, adaptive evolution.

Core Quantitative Parameters for Bottleneck Management

Parameter Typical Range in OrthoRep Impact on Diversity Recommended Mitigation Strategy
Selection Passaging Rate Every 12-72 hrs High rate increases drift; low rate allows negative mutants to persist. Titrate passaging to match mutant generation rate (1-5 doublings between passages).
Inoculum Size 1e5 - 1e7 cells <1e5 cells risks stochastic loss of rare variants. Maintain >1e6 cells at each transfer. Use pooled, not single-colony, inocula.
Selection Pressure Magnitude e.g., Drug [IC50] to [10x IC50] Very high pressure (>>IC90) can eliminate all but a few clones. Apply pressure just above the IC50 of the starting population. Ramp up gradually.
Effective Population Size (Nₑ) 1e6 - 1e8 Determines genetic drift. Nₑ < 1e5 is high risk for bottleneck. Monitor via deep sequencing of target plasmid barcodes pre/post passage.
Mutation Load (µ) ~10⁻⁵ mutations/bp/generation (OrthoRep TP-DNA) High µ can compensate for tighter bottlenecks by rapidly generating new diversity. For stringent selection, ensure high-fidelity host genome with hypermutating TP-DNA.

Protocol 1: Titrating Selection Pressure for OrthoRep Evolution

Objective: To establish a starting selection regime that enriches for improved function without causing a diversity-collapsing bottleneck.

Materials:

  • Research Reagent Solutions Table:
    Item Function Example/Supplier
    OrthoRep Yeast Strain (S. cerevisiae with p1 [CP-DNA] & p2 [TP-DNA]) Host for in vivo evolution of target gene on TP-DNA. pARC8 backbone with gene of interest cloned into TP-DNA.
    Selection Agent (Drug/Inhibitor) Applies selective pressure on the function of the evolved target. Compound stock solution in DMSO or water.
    Synthetic Defined (SD) Media (lacking appropriate amino acids) Maintains selection for OrthoRep plasmids. -Ura -Trp for standard p1/p2 retention.
    Deep Sequencing Primers (for TP-DNA amplicon) Enables quantification of population diversity and bottleneck detection. Illumina-compatible primers flanking target gene.
    Liquid Handling Robot Enables precise, high-throughput passaging and inoculation. Beckman Coulter Biomek, Hamilton STAR.

Procedure:

  • Determine Baseline IC₅₀: Grow the ancestral OrthoRep strain in a 96-well plate with a 2-fold serial dilution of the selection agent. Fit a dose-response curve after 24-48 hours of growth (OD₆₀₀) to calculate the half-maximal inhibitory concentration (IC₅₀).
  • Initiate Evolution Lines: Set up multiple independent 5 mL cultures in SD media. Inoculate each at an OD₆₀₀ of ~0.05 (≥1x10⁶ cells).
  • Apply Sub-Lethal Pressure: To all lines, add selection agent at a concentration of 1.0x to 1.5x the ancestral IC₅₀.
  • Passaging Regimen: Grow cultures with shaking at 30°C. Monitor growth. Once cultures reach mid-log phase (OD₆₀₀ ~0.8-1.0), passage 1:100 into fresh media with the same drug concentration. Record the number of generations between passages.
  • Diversity Monitoring (Checkpoint - Every 10 passages): Harvest 1 mL of culture from each line. Isolate TP-DNA and prepare amplicon libraries for deep sequencing of the target gene. Calculate Shannon Entropy or Number of Haplotypes relative to passage 0.
  • Pressure Adjustment: If diversity metrics drop by >80%, reduce the selection pressure to 0.8x of the current concentration for the next 5 passages. If growth rates recover substantially, consider a gradual ramp.

Protocol 2: Sequential Passaging with Dilution Control to Maintain Nₑ

Objective: To mechanically prevent population bottlenecks during serial transfer.

Procedure:

  • Calculate Minimum Inoculum: Based on the target Nₑ, determine the required number of cells. Ensure the inoculum volume contains ≥ 1x10⁷ cells.
  • High-Volume Passage: Instead of a standard 1:100 dilution from a saturated culture, always passage from a mid-log phase culture.
  • Centrifugation & Resuspension: For precise control, pellet the required cell number from the parent culture, then resuspend in the correct volume of fresh, pre-warmed selective media to achieve the starting OD₆₀₀. This avoids the variability of dilution from dense cultures.
  • Back-up Archiving: At each passage, archive 1 mL of culture with 15% glycerol at -80°C. This frozen "fossil record" allows retrospective analysis if a beneficial variant is lost stochastically.

Diagram 1: OrthoRep Selection Balance Workflow

G Start Start Evolution Ancestral Pool IC50 Determine Ancestral IC50 Start->IC50 Apply Apply Selection (1.0-1.5x IC50) IC50->Apply Passage Passage at Mid-Log Phase Apply->Passage Monitor Monitor Diversity via Deep Seq Passage->Monitor Decision Diversity Loss >80%? Monitor->Decision Adjust Reduce Pressure & Recover Decision->Adjust Yes Continue Continue or Ramp Pressure Decision->Continue No Adjust->Passage Next Passage Continue->Passage Next Passage

Diagram 2: Factors in Selection Bottleneck

G Bottleneck Population Bottleneck (Loss of Diversity) HighPressure High Selection Pressure HighPressure->Bottleneck SmallInoc Small Inoculum Size LowNe Low Effective Pop. Size (Nₑ) SmallInoc->LowNe FastPassage Rapid/Frequent Passaging HighDrift Increased Genetic Drift FastPassage->HighDrift HighDrift->Bottleneck LowNe->Bottleneck

The Scientist's Toolkit: Essential Reagents for OrthoRep Bottleneck Management

Item Function in Bottleneck Management Key Consideration
Barcoded TP-DNA Library Enables precise, quantitative tracking of lineage abundance and diversity via NGS. Use unique molecular identifiers (UMIs) to correct for PCR amplification bias.
Automated Cell Counter Ensures accurate and reproducible inoculation above the bottleneck threshold (e.g., >1e6 cells). Prefer fluorescence-based (e.g., Guava, NucleoCounter) over hemocytometer for yeast.
Liquid Culture Turbidostat Maintains continuous culture at mid-log phase, eliminating growth phase variability during passaging. Superior to chemostat for maintaining high Nₑ as it avoids nutrient limitation.
High-Fidelity Host Genome Strain Minimizes background adaptive mutations in the host, focusing selection on the TP-DNA target. Use repair-deficient (e.g., rad52Δ) or mutagenesis-proofread strains if available.
Population Genomics Software (e.g., PopGenome, LoFreq) Analyzes NGS data to calculate haplotype diversity, effective population size (Nₑ), and detect selection. Critical for making data-driven decisions on adjusting selection pressure.

Managing Plasmid Copy Number and Its Impact on Selection and Mutational Load

Application Notes

Within the context of OrthoRep, a continuous in vivo evolution platform that uses orthogonal error-prone DNA polymerases replicated on cytoplasmic linear plasmids (p1/p2), managing copy number is critical. The OrthoRep system in Saccharomyces cerevisiae consists of the high-copy (~100 copies/cell) p1 plasmid and the low-copy (~10 copies/cell) p2 plasmid, the latter of which is typically targeted for mutagenesis.

Key Quantitative Relationships:

  • Copy Number vs. Selection Stringency: Lower plasmid copy number increases the stringency of selection for beneficial mutations, as each plasmid contributes a smaller fraction of the total gene product. This helps isolate mutations with strong phenotypic effects.
  • Copy Number vs. Mutational Load: Higher plasmid copy number, when coupled with error-prone replication, can increase the total mutational load per cell. However, it also buffers against deleterious mutations through complementation by wild-type copies.
  • OrthoRep-Specific Dynamics: In OrthoRep, mutagenesis is focused on the low-copy p2. This design limits the mutational load per cell while allowing the rapid accumulation of mutations on a small number of physically linked genes.

Table 1: Impact of Plasmid Copy Number on Evolutionary Parameters

Parameter High Copy Number (~100) Low Copy Number (~10) OrthoRep (p2-specific) Context
Selection Stringency Lower (weak mutations can complement) Higher (phenotype per plasmid is critical) High stringency on target genes.
Mutational Load per Cell High total mutations, but buffered. Lower total mutations. Contained to p2; host genome remains stable.
Rate of Variant Generation High (more template molecules). Lower. High due to dedicated error-prone polymerase.
Variant Diversity per Cell High (heteroplasmy possible). Low (often homozygous). Focused diversity on genes of interest.

Table 2: Comparative Metrics: OrthoRep vs. Conventional Plasmid Systems

System Typical Copy Number Mutation Rate (per bp per gen.) Primary Use Case
OrthoRep (p2 plasmid) 10 ~10⁻⁵ (targeted) Continuous in vivo evolution of pathways.
High-copy ColE1 origin 500+ Host-dependent (~10⁻¹⁰) Protein over-expression, screening.
Low-copy SC101 origin ~5 Host-dependent (~10⁻¹⁰) Toxic gene expression, metabolic engineering.
Error-prone plasmid Variable (50-200) 10⁻⁶ to 10⁻⁴ (global) Library generation in vitro.

Protocols

Protocol 1: Quantifying Plasmid Copy Number inS. cerevisiaevia qPCR

Objective: Determine the average copy number per cell of OrthoRep p1 and p2 plasmids. Materials: See "Research Reagent Solutions" below. Procedure:

  • Culture & Harvest: Grow yeast strain harboring OrthoRep system to mid-log phase (OD₆₀₀ ~0.8) in appropriate selective media. Harvest 5 mL of culture.
  • Genomic DNA Extraction: Use a yeast genomic DNA extraction kit. Include a step to ensure efficient lysis of cells (e.g., lyticase pretreatment). Elute DNA in 100 µL TE buffer.
  • qPCR Assay Setup: Design primers targeting:
    • Target Gene (T): A unique sequence on the plasmid of interest (e.g., a gene on p2).
    • Reference Gene (R): A single-copy genomic locus (e.g., ACT1). Prepare a master mix with SYBR Green and primers. Use serially diluted genomic DNA of known concentration to generate standard curves for both T and R.
  • Calculation: Copy Number = (Quantity of Target Gene) / (Quantity of Reference Gene). Perform on biological triplicates.
Protocol 2: Modifying Selection Pressure During OrthoRep Evolution

Objective: Adjust selection stringency to influence the emergence of beneficial mutations. Procedure:

  • Titratable Selection:
    • For antibiotic resistance: Use a gradient of antibiotic concentration in solid or liquid media.
    • For auxotrophy complementation: Use media with limiting concentrations of the essential metabolite.
  • Continuous Evolution Setup: Inoculate OrthoRep strain into a turbidostat or chemostat. Set the dilution rate and media composition to apply the desired selective pressure (e.g., sub-inhibitory antibiotic level).
  • Monitoring: Sample the population periodically. Use Protocol 1 to monitor plasmid stability and Protocol 3 to assess mutational load.
Protocol 3: Assessing Mutational Load via Deep Sequencing

Objective: Quantify the mutation frequency and spectrum on the OrthoRep plasmid versus the host genome. Procedure:

  • Post-Evolution Sampling: Isolate plasmid DNA (for p2) and genomic DNA from an evolved OrthoRep population.
  • Library Preparation & Sequencing: Use a PCR-based amplicon sequencing approach to target the entire evolved gene(s) on p2 and a control genomic region. Sequence on an Illumina platform to high coverage (>1000x).
  • Bioinformatic Analysis:
    • Align reads to reference sequences using tools like BWA.
    • Call variants using a sensitive variant caller (e.g., LoFreq).
    • Calculate mutation frequency (mutations/bp) and spectrum for p2 vs. the genomic region.

Visualizations

orthorep_workflow Start Start Continuous Evolution CN_Low Low p2 Copy Number (~10/cell) Start->CN_Low CN_High High p2 Copy Number (Engineered Variant) Start->CN_High Sel_Strong Strong Selective Pressure CN_Low->Sel_Strong Sel_Weak Weak Selective Pressure CN_High->Sel_Weak Outcome1 Outcome: High Stringency Few, Strong Mutations Sel_Strong->Outcome1 Outcome2 Outcome: Buffered Load Diverse, Weaker Mutations Sel_Weak->Outcome2

Title: Copy Number and Selection in OrthoRep Evolution

mutational_load HighCN High Plasmid Copy Number MutLoadCell High Total Mutations per Cell HighCN->MutLoadCell LowCN Low Plasmid Copy Number StrongSelect Strong Selection per Plasmid LowCN->StrongSelect ErrPol Error-Prone Replication ErrPol->MutLoadCell Buffer Complementation (Buffering) MutLoadCell->Buffer OutcomeA Outcome: High Diversity Low Stringency Buffer->OutcomeA Leads to OutcomeB Outcome: Focused Diversity High Stringency StrongSelect->OutcomeB Leads to

Title: Factors Affecting Mutational Load and Selection

The Scientist's Toolkit: Research Reagent Solutions

Item Function in Context
OrthoRep S. cerevisiae Strain Engineered yeast with orthogonal DNA replication system (p1/p2 plasmids). Essential for all experiments.
p2 Plasmid with Target Gene The low-copy, error-prone replicated plasmid that harbors the gene(s) to be evolved.
Error-Prone Orthogonal Polymerase The mutated DNA polymerase (e.g., TP-DNAP1) that specifically replicates p2 at high error rates.
Lyticase (Zymolyase) Enzyme for digesting yeast cell walls prior to genomic DNA extraction, ensuring efficient lysis.
qPCR Master Mix (SYBR Green) For accurate, quantitative amplification of plasmid and genomic DNA targets for copy number assay.
Selective Media Components Antibiotics (e.g., G418), nutrient drop-out mixes, or titratable inhibitors to apply precise selection pressure.
Amplicon Sequencing Library Prep Kit For preparing high-fidelity, barcoded NGS libraries from evolved plasmid and genomic DNA targets.
Turbidostat or Chemostat Bioreactor Enables continuous, steady-state culture for applying constant selective pressure over long-term evolution.

Troubleshooting Poor Library Representation and Genetic Drift

Application Notes

OrthoRep is a yeast-based continuous in vivo evolution system that utilizes a cytoplasmic orthogonal DNA polymerase-plasmid pair. The system enables the rapid evolution of target genes through error-prone replication. However, two critical challenges in long-term evolution experiments are Poor Library Representation (inefficient transformation leading to skewed variant libraries) and Genetic Drift (stochastic loss of beneficial variants in small populations). These issues directly impact the efficacy of evolutionary campaigns for drug target engineering and enzyme optimization in therapeutic development.

Quantitative Analysis of Common Failure Points

The following table summarizes quantitative benchmarks and failure thresholds observed in OrthoRep experiments.

Table 1: Key Metrics for Diagnosing Library and Drift Issues

Metric Target Range (Healthy Experiment) Problematic Range Primary Implication
Transformation Efficiency >1x10⁴ CFU/µg plasmid <1x10³ CFU/µg plasmid Poor Library Representation
Initial Library Diversity >10⁵ unique clones <10⁴ unique clones Poor Library Representation
Effective Population Size (Nₑ) Nₑ > 10⁴ cells Nₑ < 10³ cells Increased Genetic Drift
Variant Loss Rate (Neutral) <5% per 20 generations >15% per 20 generations High Genetic Drift
Mutation Rate (Target Gene) ~10⁻⁵ mutations/bp/ gen <10⁻⁶ or >10⁻⁴ mutations/bp/gen Uncontrolled evolution
Plasmid Copy Number 10-20 copies/cell <5 or >30 copies/cell Unstable selection pressure
Protocols for Troubleshooting
Protocol 1: Optimizing Library Construction for Maximal Representation

Objective: To achieve high-efficiency transformation and even representation of all variants in the initial yeast library. Materials: See "Research Reagent Solutions" (Table 2).

  • Vector Preparation: Linearize the acceptor plasmid (pOR) with BsaI-HFv2 at 37°C for 1 hour. Gel-purify the fragment. Critical: Verify complete digestion to reduce background.
  • Gibson Assembly: Use a 2:1 molar ratio of insert (mutant gene pool) to vector. Assemble with 2X Gibson Master Mix for 1 hour at 50°C.
  • Ethanol Precipitation: Add 0.6 volumes of room-temperature isopropanol, incubate at RT for 10 min, centrifuge at max speed for 15 min. Wash with 70% ethanol. Resuspend in 10 µL nuclease-free water.
  • High-Efficiency Yeast Transformation: Use the LiAc/SS Carrier DNA/PEG method.
    • Inoculate 5 mL of YPD and grow to saturation.
    • Dilute to OD₆₀₀ ~0.25 in 50 mL fresh YPD, grow to OD₆₀₀ ~0.8-1.0.
    • Harvest, wash with 25 mL sterile water, then 1 mL 100 mM LiAc.
    • Resuspend pellet in 500 µL 100 mM LiAc.
    • For each reaction, mix: 50 µL cells, 10 µL carrier DNA (boiled and cooled), 5 µL assembly product, 300 µL 40% PEG-3350/100 mM LiAc.
    • Heat shock at 42°C for 40 minutes. Pellet cells, resuspend in 1 mL YPD, recover at 30°C for 90 min.
    • Plate on appropriate -Ura/-Trp selective media. Aim for colonies >10x library diversity.
  • Library Harvesting: After 72 hours, scrape all colonies (>100,000) into 10 mL of glycerol stock medium (YPD + 25% glycerol). Mix thoroughly, aliquot, and freeze at -80°C.
Protocol 2: Minimizing Genetic Drift During Continuous Evolution

Objective: To maintain variant diversity and reduce stochastic loss.

  • Determining Bottleneck Size:
    • Inoculate evolution lines from the master library stock to an initial OD₆₀₀ of 0.1 in selective medium.
    • Grow to late log phase (OD₆₀₀ ~2.0). This defines one "growth cycle" (~10 generations).
    • For each serial passage, use a large, calculated inoculum to maintain a large Nₑ. Formula: Inoculum Volume (mL) = (Target Nₑ) / (Harvest OD₆₀₀ * 3x10⁷ cells/mL*OD).
    • Example: For Target Nₑ = 50,000 and Harvest OD=2.0, use ~0.83 mL of culture to inoculate the next cycle.
  • Parallel Evolution Lines: Maintain a minimum of 12 independent evolution lines in parallel. This allows distinction between drift (variants lost stochastically in only some lines) and selection (variants consistently lost or fixed across lines).
  • Periodic Deep Sequencing Census: Every 50 generations, harvest 5 mL from each line. Isolate OrthoRep plasmid DNA (protocol below) and perform NGS of the target gene. Analyze variant frequency to track drift.
Protocol 3: OrthoRep Plasmid DNA Isolation for Sequencing

Objective: To purify the cytoplasmic OrthoRep plasmid, free of genomic DNA.

  • Harvest 5 mL of yeast culture (OD₆₀₀ ~2.0) by centrifugation.
  • Resuspend in 250 µL of Lysis Buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA) with 0.3 g of acid-washed glass beads.
  • Vortex vigorously for 5 minutes.
  • Add 250 µL of Phenol:Chloroform:Isoamyl Alcohol (25:24:1), vortex for 2 minutes.
  • Centrifuge at 16,000 x g for 10 minutes at 4°C. Transfer aqueous phase to a new tube.
  • Precipitate DNA with 0.7 volumes of isopropanol, wash with 70% ethanol.
  • Resuspend in 50 µL TE buffer with RNase A. This yields a mix of gDNA and OrthoRep plasmid.
  • Use 1 µL of this as template in a 20 µL PCR with primers specific to the target gene on the OrthoRep plasmid. Purify PCR product for NGS library prep.
Research Reagent Solutions

Table 2: Essential Materials for OrthoRep Troubleshooting

Reagent / Material Function / Rationale Example (Supplier)
BsaI-HFv2 Restriction Enzyme High-fidelity digestion of acceptor plasmid; prevents re-ligation background. NEB, Cat# R3733
2X Gibson Assembly Master Mix Efficient, seamless assembly of mutant gene pool into linearized vector. NEB, Cat# E2611
Single-Stranded Carrier DNA Boosts transformation efficiency in yeast LiAc protocol. Thermo Fisher, Cat# 15632019
PEG-3350 (40% w/v) Essential component of yeast transformation mixture. Sigma-Aldrich, Cat# 1546545
Acid-Washed Glass Beads (425-600 µm) Mechanical lysis of yeast cell walls for plasmid extraction. Sigma-Aldrich, Cat# G8772
Orthogonal DNA Pol Plasmid Kit Specialized kit for purifying OrthoRep plasmid from yeast. (e.g., Zymo Research Y-Duet)
NGS Library Prep Kit for Amplicons Preparing variant libraries from harvested OrthoRep plasmids for census sequencing. Illumina, Cat# 20060059
Diagrams

troubleshooting_workflow Start Identify Problem: Failed Evolution A Sequence Initial Library Pool Start->A B Check Transformation Efficiency Start->B C Assess Population Size & Passaging Start->C D1 Skewed Variant Frequencies A->D1 D2 Low Colony Count (<10³ CFU/µg) B->D2 D3 Small Bottleneck (Nₑ < 10³) C->D3 S1 Poor Library Representation D1->S1 D2->S1 S2 High Genetic Drift D3->S2 P1 Protocol 1: Optimize Library Construction S1->P1 P2 Protocol 2: Minimize Drift S2->P2

Troubleshooting Decision Tree for OrthoRep Issues

orthorep_mechanism OrthoRep System & Drift Causes cluster_ortho OrthoRep System Pol Orthogonal DNA Polymerase TP Orthogonal Plasmid Pair Pol->TP Replicates TG Target Gene (to be evolved) TP->TG Harbors Ext External Selection Pressure (e.g., Drug, Substrate) TG->Ext Phenotype Nuc Nucleus (Genomic DNA) Nuc->Pol Encodes Cyt Cytoplasm Cyt->TP Drift Genetic Drift VarLoss Stochastic Variant Loss Drift->VarLoss SmallPop Small Effective Population Size (Nₑ) SmallPop->Drift Bottleneck Population Bottlenecks Bottleneck->Drift

OrthoRep System Components and Genetic Drift Causes

Application Notes

Within the broader thesis of OrthoRep-driven in vivo evolution, a pivotal advancement lies in coupling OrthoRep's targeted, hyper-mutating capabilities with engineered transcriptional regulators to create powerful selection systems for novel functions. OrthoRep (S. cerevisiae cytosolic orthogonal replication system) enables continuous, in vivo evolution of target genes by linking their mutation to an error-prone orthogonal DNA polymerase (p1). This system, however, requires effective selection or screening strategies to isolate desired variants.

The integration of synthetic transcriptional regulators—such as engineered zinc finger proteins (ZFPs), transcription activator-like effectors (TALEs), or CRISPR/dCas9 systems—provides a direct link between the activity of an evolving protein and host cell survival or reporter expression. By placing an essential gene or a fluorescent reporter under the control of a promoter responsive to these regulators, whose DNA-binding or activation is itself dependent on the activity of the OrthoRep-evolved target, researchers can create self-contained evolution platforms. For instance, evolving a protease can be linked to the cleavage and release of a transcriptional activator from the membrane, driving expression of HIS3 for selection on media lacking histidine.

Table 1: Comparison of Transcriptional Regulator Systems for Coupling with OrthoRep

Regulator Type Mutability Ease of Engineering Dynamic Range Common Selection Output
Zinc Finger (ZFP) Low (protein scaffold) Moderate to Difficult ~10-50 fold URA3 (5-FOA resistance/sensitivity), HIS3
TALE Low (protein scaffold) Moderate (modular assembly) ~50-100 fold GFP (FACS), ADE2 (colorimetric)
CRISPR/dCas9 High (gRNA sequence) Easy (gRNA redesign) ~100-1000 fold mCherry (sorting), CAN1 (toxin resistance)
Bacterial Repressor (e.g., TetR) Medium (DNA-binding specificity) Easy (promoter engineering) ~100 fold LEU2, URA3

Protocol: Coupling OrthoRep-Evolving Protease to a dCas9-Activator System for Selection

Objective: To evolve a protease with novel cleavage specificity using OrthoRep, where successful variants cleave a membrane-tethered dCas9-VP64 activator, driving expression of the URA3 reporter for selection on 5-fluoroorotic acid (5-FOA).

Part 1: Strain and Plasmid Construction

  • Yeast Strain Engineering:
    • Start with a yeast strain harboring the OrthoRep system (p1 mutator plasmid and p2 target plasmid).
    • Integrate a URA3 reporter gene driven by a minimal promoter containing a gRNA-targetable sequence into a genomic safe-haven locus (e.g., HO site).
    • Integrate a gene encoding a membrane-anchored, protease-cleavable dCas9-VP64 fusion protein. The linker between dCas9 and the transmembrane domain should contain the wild-type cleavage sequence for the protease of interest.
  • Target Plasmid (p2) and gRNA Plasmid Construction:
    • Clone the gene for the protease to be evolved into the OrthoRep p2 plasmid.
    • Clone a gRNA sequence targeting the URA3 reporter's promoter into a constitutively expressed gRNA expression plasmid.

Part 2: Evolution and Selection Cycle

  • Transformation: Transform the constructed yeast strain with the p2-protease plasmid and the gRNA plasmid.
  • Culture Propagation: Inoculate cells into selective -Leu/-Trp media (to retain plasmids) and propagate for ~24-48 hours (approximately 10-15 generations) to allow OrthoRep-driven mutation of the protease gene.
  • Selection Pressure:
    • Plate the propagated culture onto synthetic complete media containing 5-FOA (1 g/L) and lacking leucine and tryptophan.
    • Logic: Only cells where the evolved protease has successfully cleaved the membrane-tethered dCas9-VP64 will release the activator. The freed dCas9-VP64, guided by the gRNA, will activate URA3 expression. Ura3p converts 5-FOA into the toxic compound 5-fluorouracil, killing cells that express it. Therefore, functional protease variants lead to survival on 5-FOA.
  • Isolation and Analysis: Pick surviving colonies, isolate the p2 plasmid, and sequence the evolved protease gene. Characterize cleavage specificity using an in vitro fluorescence assay.

G cluster_1 Initial State cluster_2 Protease Activity cluster_3 Selection Outcome title OrthoRep-dCas9 Evolution Workflow Prot_in OrthoRep-evolved Protease Cleavage Cleavage Event Prot_in->Cleavage Mutations dCas9_in Membrane-tethered dCas9-VP64 dCas9_in->Cleavage Reporter_in URA3 Reporter (OFF) gRNA gRNA dCas9_free Freed dCas9-VP64 Cleavage->dCas9_free Reporter_on URA3 Reporter (ON) dCas9_free->Reporter_on + gRNA Toxicity 5-FOA → 5-FU Cell Death Reporter_on->Toxicity Expression Survival 5-FOA Resistance (Survival) Toxicity->Survival Negative Selection

The Scientist's Toolkit: Research Reagent Solutions

Item Function in Experiment
OrthoRep p1 & p2 Plasmid System Foundational chassis for targeted, continuous in vivo mutagenesis of the gene of interest.
S. cerevisiae Strain with Genomic Integrations Engineered host containing stably integrated reporter (URA3) and regulator (dCas9-VP64) constructs.
dCas9-VP64 Fusion Plasmid Provides the transcriptional activator component; VP64 domain drives strong gene expression.
gRNA Expression Plasmid Directs the dCas9-VP64 activator to the specific promoter controlling the selection reporter.
5-Fluoroorotic Acid (5-FOA) Selective agent: cells expressing URA3 convert it to toxic 5-fluorouracil, enabling negative selection.
Error-Prone Orthogonal DNA Polymerase (p1 variant) Drives the hyper-mutation (10^-5 substitutions/base/generation) of the target gene on plasmid p2.
Protease-Specific Fluorogenic Substrate For in vitro validation of evolved protease activity and specificity post-selection.

G title Transcriptional Coupling Logic GOI OrthoRep-Evolving Gene of Interest (GOI) Activity GOI Activity (e.g., binding, catalysis) GOI->Activity TR Transcriptional Regulator (e.g., ZFP, dCas9) State Regulator State/Activity TR->State Activity->State Modulates Reporter Reporter Gene Expression (HIS3, URA3, GFP) State->Reporter Drives Selection Phenotypic Selection (Growth, Fluorescence) Reporter->Selection

OrthoRep vs. Other Systems: Validating Performance and Choosing the Right Evolution Platform

Within the broader thesis on OrthoRep in vivo evolution systems, this Application Note provides a detailed, practical comparison with the seminal Phage-Assisted Continuous Evolution (PACE) platform. Both systems enable continuous, rapid protein evolution without manual intervention, yet their architectures, host contexts, and operational scales differ fundamentally. This document provides quantitative comparisons, detailed protocols for implementation, and key reagent toolkits to guide researchers in selecting and deploying these powerful technologies for directed evolution campaigns.

Table 1: Core System Architecture & Performance Comparison

Feature OrthoRep Phage-Assisted Continuous Evolution (PACE)
Evolution Principle Error-prone, orthogonal DNA polymerase in yeast (cytoplasmic plasmid). Phage life cycle coupled to host cell survival and activity-dependent gene III complementation in E. coli.
Host Organism Saccharomyces cerevisiae (Eukaryotic). Escherichia coli (Prokaryotic).
Genetic Target Cytoplasmic linear plasmid (~1-10 kb capacity). Bacteriophage genome (specifically gene of interest within M13 phage).
Mutation Rate Tunable, ~10^-5 substitutions per base per replication. Continuous, driven by host mutagenesis plasmids (e.g., mutagenic T7 RNAP).
Evolution Timeline Continuous serial passaging in culture; days to weeks for multiple rounds. Extremely fast; ~200 phage generations per day (30+ rounds of evolution per day).
Key Throughput Library of ~10^7 evolving sequences per population. Vast population sizes (~10^10 phage particles in lagoon).
Selection/ Screens In vivo selection via host growth or fluorescence; can be linked to host function. Continuous selection based on phage infectivity, directly linked to protein activity.
Protein Types Evolved Cytosolic, membrane-associated, and pathway-embedded eukaryotic proteins. Primarily prokaryotic proteins, enzymes, binders; some eukaryotic proteins with functional expression in E. coli.

Table 2: Practical Implementation & Resource Requirements

Aspect OrthoRep PACE
Specialized Equipment Standard yeast culture (shakers, spectrophotometers). Continuous culture apparatus (lagoon system, peristaltic pumps).
Setup Complexity Moderate (yeast transformation, plasmid maintenance). High (lagoon setup, phage titering, host strain preparation).
Operational Duration Passaging every 24-48 hours; manual intervention required. Once running, continuous for days to weeks with minimal intervention.
Key Readouts Population phenotype (growth, fluorescence), plasmid sequencing. Phage titer from effluent, sequencing of output phage.
Maximum Gene Size ~3-5 kb optimal for the cytoplasmic plasmid. Limited by phage packaging (~3-5 kb for gene III fusions).

Detailed Protocols

Protocol 1: OrthoRep – Initiation of a Continuous Evolution Campaign for a Yeast Metabolic Enzyme

Objective: To evolve a novel activity in a metabolic enzyme expressed from the OrthoRep cytoplasmic plasmid in Saccharomyces cerevisiae.

Materials: See "The Scientist's Toolkit" below.

Procedure:

  • Gene Cloning into pCR: Amplify your gene of interest (GOI) with homology arms to the pCR plasmid. Perform homologous recombination in vivo by co-transforming the linearized pCR plasmid and the PCR product into the OrthoRep yeast strain (e.g., yWR-3) using a standard lithium acetate protocol. Select on synthetic defined (SD) media lacking uracil.
  • Validation of Clones: Isolate plasmid DNA from yeast clones. Perform diagnostic PCR and Sanger sequencing to confirm the GOI is correctly inserted into the pCR plasmid and that the orthogonal DNA polymerase (p1 plasmid) is present.
  • Establishing Evolution Conditions: Inoculate a positive clone into 5 mL of SD -Ura liquid medium. Grow to saturation (typically 24-48 hrs). This is your P0 population.
  • Serial Passaging Under Selection: Dilute the saturated culture 1:1000 into fresh SD -Ura medium containing the selective pressure (e.g., a non-native substrate required for growth, or an inhibitor). Incubate at 30°C with shaking.
  • Monitoring Evolution: At each passage (every 24-48 hours), record the culture's optical density (OD600) at saturation. Periodically (e.g., every 10 passages), harvest cells and extract the pCR plasmid using a yeast plasmid miniprep kit. Sequence the GOI region via NGS to track mutation accumulation.
  • Isolation and Characterization: After observing improved phenotype, isolate single colonies. Extract pCR plasmids from individual clones, transform into E. coli for amplification, and sequence. Re-transform purified plasmid into a fresh OrthoRep strain to confirm phenotype linkage.

Protocol 2: PACE – Evolution of a Protease Substrate Specificity

Objective: To evolve the specificity of a tobacco etch virus (TEV) protease using a PACE selection that links desired cleavage activity to phage propagation.

Materials: See "The Scientist's Toolkit" below.

Procedure:

  • Construct Phage Plasmid (pAPP): Clone the gene for the protease variant library (e.g., error-prone PCR product of TEV protease gene) into the pAPP vector as an N-terminal fusion to the N-terminal domain of gene III (gIII-N). The designed cleavage site (target sequence) is placed between the protease and gIII-N.
  • Prepare Host Cells (S2060 E. coli): Transform the E. coli host strain with the accessory plasmid (pACS) expressing the C-terminal domain of gIII (gIII-C) and any required selection components. Grow overnight.
  • Set Up the Lagoon: Dilute the overnight host culture 1:100 into 50 mL of LB medium with antibiotics in the lagoon vessel. Start medium inflow (fresh LB with hosts and arabinose to induce pACS) and outflow using peristaltic pumps. Maintain lagoon volume at 50 mL with a dilution rate of ~1 lagoon volume per hour.
  • Initiate PACE: Infect the lagoon with the initial phage library (pAPP) at a low multiplicity of infection (MOI < 0.1). Collect effluent (output phage) continuously.
  • Titer Effluent Phage: Periodically (every 4-12 hours), take samples from the effluent. Serially dilute and mix with fresh host cells in a top agar plaque assay to determine phage titer (PFU/mL). A rising titer indicates successful evolution.
  • Harvest and Sequence Evolved Phage: After 24-96 hours of PACE, when titers stabilize or rise significantly, precipitate phage from the effluent using PEG/NaCl. Isolate ssDNA from phage particles, convert to dsDNA, and PCR-amplify the protease gene for NGS or Sanger sequencing of individual clones.
  • Characterization: Clone individual evolved protease variants into an expression vector for biochemical characterization of their new cleavage specificity and kinetics.

System Diagrams

OrthoRep_Workflow Start Clone GOI into OrthoRep plasmid (pCR) Transform Transform into OrthoRep yeast strain Start->Transform Passage Serial passaging in selective liquid culture Transform->Passage OrthoPoly Orthogonal DNA pol (p1) mutates pCR plasmid Passage->OrthoPoly Continuous Select Selection for improved phenotype enriches mutants OrthoPoly->Select Select->Passage Dilution into fresh media Harvest Harvest cells, extract pCR plasmid Select->Harvest Sequence Sequence GOI (NGS/Sanger) Harvest->Sequence Validate Validate variant function Sequence->Validate

Title: OrthoRep Continuous Evolution Workflow

PACE_Workflow Library Generate phage library (pAPP) Infect Infect lagoon with initial phage Library->Infect Host Prepare E. coli host with accessory plasmid Lagoon Set up continuous culture lagoon Host->Lagoon Flow Continuous inflow of fresh hosts & outflow Lagoon->Flow Lifecycle Activity-dependent gIII complementation Infect->Lifecycle Flow->Lifecycle Continuous Effluent Collect effluent containing phage Lifecycle->Effluent Effluent->Infect Re-infect lagoon if needed Titer Titer phage (PFU/mL) Effluent->Titer SequencePACE Sequence evolved phage genome Titer->SequencePACE

Title: PACE System Operational Workflow

Selection_Logic cluster_OrthoRep OrthoRep Selection cluster_PACE PACE Selection OR_GOI GOI on pCR plasmid in yeast OR_Mutate Orthogonal pol generates mutations OR_GOI->OR_Mutate OR_Pheno Variant affects host cell phenotype OR_Mutate->OR_Pheno OR_Growth Altered host growth/survival OR_Pheno->OR_Growth OR_Enrich Enrichment of beneficial variants OR_Growth->OR_Enrich PACE_Phage Phage carries GOI-gIII fusion PACE_Activity GOI activity cleaves/activates PACE_Phage->PACE_Activity PACE_gIII Functional gIII restored PACE_Activity->PACE_gIII PACE_Infect Phage can infect new host cell PACE_gIII->PACE_Infect PACE_Prop Variant propagates PACE_Infect->PACE_Prop

Title: Core Selection Logic in OrthoRep vs PACE

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions for OrthoRep

Reagent/Material Function in Experiment
OrthoRep Yeast Strain (e.g., yWR-3) Engineered S. cerevisiae harboring the orthogonal p1 plasmid (encoding error-prone DNA pol) and the target pCR plasmid. The chassis for evolution.
pCR Plasmid Backbone Cytoplasmic linear plasmid replicated by the orthogonal pol. Accepts the gene of interest for targeted mutagenesis.
SD -Ura Media Selective medium to maintain both the p1 (TRP1) and pCR (URA3) plasmids during culturing and passaging.
Chemical Substrates/Inhibitors Provides the selective pressure for evolution (e.g., toxic compound for resistance, novel substrate for growth).
Yeast Plasmid Miniprep Kit For extraction of pCR plasmid from yeast populations for sequencing analysis during the evolution campaign.

Table 4: Key Research Reagent Solutions for PACE

Reagent/Material Function in Experiment
M13 Phage Vector (e.g., pAPP) Cloning vector that allows fusion of the GOI to the N-terminus of gene III (gIII), linking protein activity to phage infectivity.
E. coli Host Strain (e.g., S2060) An E. coli strain engineered for PACE, typically deleted for the F' pilus and containing a chromosomal copy of gene III under a regulated promoter.
Accessory Plasmid (pACS) Supplies essential components like the C-terminal fragment of gIII and inducers (e.g., arabinose-inducible gIII-C).
Lagoon Apparatus Continuous culture vessel with regulated inflow of fresh medium/host cells and outflow of waste and progeny phage.
PEG/NaCl Solution Used to precipitate phage particles from large volumes of lagoon effluent for DNA extraction and sequencing.

Application Notes

1. System Overview and Quantitative Comparison OrthoRep is an in vivo continuous evolution system in yeast, utilizing an error-prone orthogonal DNA polymerase-plasmid pair to mutate a gene of interest (GOI) in situ. Yeast display is an in vitro display technology that links genotype (surface-anchored protein) to phenotype (binding affinity) for screening. The following table summarizes core characteristics:

Table 1: Core System Comparison

Feature OrthoRep Yeast Display Phage Display (In Vitro Reference)
Evolution Environment In vivo (yeast cytoplasm) In vitro (yeast surface) In vitro (phage coat)
Mutation Generation Continuous, in vivo by orthogonal pol Separate library construction (e.g., error-prone PCR) Separate library construction
Throughput ~10^6 variants screened per cycle ~10^7 - 10^9 variants screened per sort ~10^9 - 10^11 variants screened per pan
Selection Pressure Direct growth selection or FACS FACS-based binding/sorting Panning against immobilized target
Typical Evolution Timeline Weeks for >10^5 cumulative mutations Days per library generation/sort cycle Days per library generation/panning cycle
Key Advantage Ultra-high mutagenesis rate; continuous evolution without bottlenecking; explores functional landscapes. Eukaryotic folding & PTMs; multi-parameter FACS; quantitative ( K_D ) measurement. Vast library sizes; well-established for antibody fragments.

Table 2: Quantitative Performance Metrics

Metric OrthoRep Yeast Display
Mutagenesis Rate ~10^-5 substitutions/base/generation (targeted) N/A (library pre-made)
Cumulative Mutations (Typical) 10^3 - 10^5 over 10-100 generations 1-10 per variant per library
Functional Library Size Limited by transformation (~10^6) Up to 10^9
Affinity Maturation Gain (Reported Examples) >1000-fold in drug resistance; >100-fold in binding affinity. Routinely achieves pM to nM ( K_D ) from μM starters.
Protein Size Limit Limited by plasmid capacity (~2kb GOI) Large proteins possible (e.g., full-length mAbs).

2. Context Within OrthoRep Thesis Research This analysis underpins the thesis that OrthoRep’s unique in vivo continuous evolution is complementary to, not a replacement for, powerful in vitro display methods like yeast display. The thesis posits that OrthoRep excels in exploring ultra-mutated sequence spaces and direct functional selections (e.g., enzymatic activity, intracellular stability), while yeast display remains superior for high-throughput affinity-based screening of complex libraries. Integrating OrthoRep-generated highly functional variants into yeast display libraries for fine-tuning represents a synergistic workflow.

Protocols

Protocol 1: OrthoRep Continuous Evolution for Drug Resistance Objective: Evolve a target enzyme for increased drug resistance via continuous passaging in yeast.

Materials: See "Scientist's Toolkit" below.

Procedure:

  • Clone GOI into OrthoRep Plasmid: Insert the gene encoding the target enzyme (e.g., human DHFR) into the p1 plasmid (orthogonal replication target) via Gibson assembly, downstream of a constitutive yeast promoter.
  • Yeast Transformation: Co-transform S. cerevisiae BY4733 (or equivalent) with the engineered p1 plasmid and the p2 plasmid expressing the error-prone orthogonal DNA polymerase (e.g., TP-DNAP1 mutator variant). Select on -Trp/-Ura media.
  • Initiate Continuous Evolution: Inoculate a single colony into 2 mL of selective SC medium. Grow to saturation (24-48 hrs, 30°C).
  • Apply Selective Pressure: Perform serial passaging by diluting saturated culture 1:100 or 1:1000 into fresh SC medium containing a concentration of target drug (e.g., methotrexate) that inhibits the wild-type enzyme. Cycle daily.
  • Monitor Evolution: Periodically (every 3-5 passages) plate dilutions on non-selective and drug plates to quantify resistance gain. Measure growth rates in liquid culture with drug.
  • Isolate & Sequence: After desired resistance is achieved, isolate plasmid DNA from yeast populations or single colonies. Subject the p1 plasmid to next-generation sequencing to identify mutations.

Protocol 2: Yeast Display Affinity Maturation Screening Objective: Screen a library of a protein variant (e.g., scFv) for increased antigen binding affinity.

Materials: See "Scientist's Toolkit" below.

Procedure:

  • Library Construction: Generate mutant library of scFv gene via error-prone PCR or oligonucleotide synthesis. Clone into yeast display vector (e.g., pYD1) for fusion with Aga2p surface anchor.
  • Yeast Transformation & Induction: Transform S. cerevisiae EBY100 with the library via electroporation. Induce expression in SG-CAA medium (20°C, 24-48 hrs).
  • Labeling for FACS: Harvest ~10^7 cells. Label with biotinylated antigen at a concentration near or below the expected ( K_D ) of the parent variant. Subsequently label with fluorescent streptavidin (e.g., SA-PE) and an anti-c-Myc antibody (for expression check) conjugated to a different fluorophore (e.g., Alexa Fluor 488).
  • Magnetic/Analytical Pre-sorting: Use magnetic bead sorting against the expression tag to remove non-expressors. Analyze by flow cytometry to set sorting gates.
  • Fluorescence-Activated Cell Sorting (FACS): Sort the top 0.1-1% of yeast cells demonstrating high antigen binding signal while maintaining high expression. Recover sorted cells in SD-CAA medium.
  • Recovery & Iteration: Grow recovered cells, re-induce, and repeat sorting with progressively lower antigen concentrations to select for higher affinity. Islect single clones from final round for characterization via flow cytometry titration to determine ( K_D ).

Visualizations

orthorep_workflow GOI Gene of Interest (GOI) Clone Clone GOI into Orthogonal Plasmid (p1) GOI->Clone Transform Co-transform Yeast with p1 & p2 (mutator pol) Clone->Transform Culture Culture under Selective Pressure Transform->Culture Mutate In vivo Continuous Mutation by OrthoRep Culture->Mutate Mutate->Mutate  ~1e-5/base/gen Evolve Propagate & Evolve (Serial Passaging) Mutate->Evolve Evolve->Evolve 1:100 Dilution Harvest Harvest Evolved Population/Clones Evolve->Harvest Seq Sequence & Analyze Mutations Harvest->Seq

Title: OrthoRep Continuous Evolution Workflow

yeast_display_workflow Lib Generate Mutant DNA Library CloneYD Clone into Yeast Display Vector Lib->CloneYD TransformYD Transform Yeast (EBY100) CloneYD->TransformYD Induce Induce Surface Expression TransformYD->Induce Label Label with Antigen & Fluorescent Probes Induce->Label FACS FACS Sort: High Binder/Expresser Label->FACS Recover Recover Sorted Cells FACS->Recover Iterate Iterate Sorting with Increased Stringency Recover->Iterate Analyze Analyze Clones: Flow Titration for Kd Recover->Analyze Iterate->Label Repeat

Title: Yeast Display Library Screening Workflow

method_decision_tree leaf leaf Q1 Primary Goal: Ultra-deep Mutagenesis & Direct Functional Selection? Q2 Primary Goal: High-throughput Affinity Screening & Fine-tuning? Q1->Q2 No OrthoRep Choose OrthoRep Q1->OrthoRep Yes Q3 Need Eukaryotic Folding & PTMs? Q2->Q3 Yes Phage Consider Phage Display Q2->Phage No (e.g., simple peptides) YeastD Choose Yeast Display Q3->YeastD Yes Q3->Phage No Integrate Synergistic Strategy: OrthoRep -> Yeast Display OrthoRep->Integrate Optional

Title: Method Selection Decision Tree

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions

Item Function / Description Typical Example/Supplier
Orthogonal Plasmid Pair (p1 & p2) p1 harbors GOI; p2 expresses error-prone orthogonal DNA polymerase. Essential for OrthoRep. Custom constructs from the lab of Frances H. Arnold or Chang C. Liu.
S. cerevisiae BY4733 Strain Engineered host yeast strain with chromosomal deletion of native plasmid system for OrthoRep. ATCC or academic stock centers.
Yeast Display Vector (pYD1) Plasmid for surface expression of Aga2p-fusion proteins in EBY100 strain. Thermo Fisher Scientific (V835-01).
S. cerevisiae EBY100 Strain Engineered for inducible surface expression from the pYD1 vector. Thermo Fisher Scientific (C839-00).
Error-Prone PCR Kit Generates random mutagenesis libraries for yeast display library construction. Jena Bioscience or Agilent Technologies.
FACS Aria Cell Sorter Instrument for high-speed, high-precision sorting of yeast display libraries based on fluorescence. BD Biosciences.
Biotinylated Antigen Critical reagent for labeling yeast-displayed binders during FACS screening. Custom synthesis via Sigma-Aldrich or Pierce.
Anti-c-Myc Antibody (FITC/AF488) Detects expression level of Aga2p-fusion protein on yeast surface. Abcam or Thermo Fisher.
Streptavidin-PE Fluorescent conjugate to detect biotinylated antigen binding. BioLegend or Thermo Fisher.
Yeast NGS Prep Kit For preparation of OrthoRep plasmid DNA from yeast for sequencing. Zymo Research YeaStar Genomic Kit or similar.

Within the context of OrthoRep's in vivo continuous evolution system, precise validation of outcomes is critical. This document details application notes and protocols for quantifying the core metrics of any directed evolution campaign: mutation spectra, mutation rates, and functional enrichment. These metrics validate the fidelity of the system, the efficiency of the evolutionary process, and the success of selection.

Quantifying Mutation Spectra

Mutation spectra describe the types and frequencies of base substitutions and indels accumulated in the evolved population or individual clones. In OrthoRep, this validates the expected error-prone replication of the orthogonal DNA polymerase and the absence of off-target genomic mutations.

Protocol 1.1: Deep Sequencing Analysis of Mutated Plasmid Pools

Objective: To characterize the global mutation spectrum from a bulk evolved population.

Materials & Workflow:

  • Harvest Cells: Isolate cells from the evolution culture after a defined number of generations.
  • Plasmid Extraction: Use a standard mini-prep kit to extract the OrthoRep cytoplasmic plasmid (p1/p2 system).
  • Amplify Target Region: Design primers to amplify the gene of interest (GOI) located on the error-prone p2 plasmid. Use a high-fidelity polymerase.
  • Library Prep & NGS: Fragment the amplicon, prepare sequencing libraries (e.g., Illumina), and perform paired-end deep sequencing (minimum 50,000x coverage).
  • Bioinformatics Analysis:
    • Align reads to the reference GOI sequence using tools like BWA or Bowtie2.
    • Call variants using a tool like LoFreq or Breseq (for haploid plasmids).
    • Filter variants by a minimum frequency (e.g., 0.1%) and quality score.
    • Categorize each mutation: C>T, G>A, A>T, etc., and note indel contexts.

Data Presentation: Table 1: Example Mutation Spectrum from an OrthoRep Evolution Run (100,000 generations)

Mutation Type Observed Count Frequency per 10kb Relative Proportion (%)
Transitions
A>G / T>C 1,542 12.8 38.5
C>T / G>A 1,185 9.9 29.6
Transversions
A>T / T>A 402 3.4 10.0
A>C / T>G 315 2.6 7.9
C>A / G>T 298 2.5 7.4
C>G / G>C 258 2.2 6.4
Insertions 45 0.4 1.1
Deletions 62 0.5 1.5
Total 4,107 34.2 100

mutation_workflow Harvest Harvest Extract Extract Harvest->Extract Evolved Culture Amplify Amplify Extract->Amplify p2 Plasmid Sequence Sequence Amplify->Sequence GOI Amplicon Align Align Sequence->Align NGS Reads Call Call Align->Call Aligned Reads Categorize Categorize Call->Categorize Variant Calls Spectrum Spectrum Categorize->Spectrum Annotated Mutations

Deep Sequencing Mutation Analysis Workflow

Calculating Mutation Rates

Mutation rate is the frequency of mutations per base per replication. In OrthoRep, the rate is measured for the p2 plasmid, which is replicated by the error-prone polymerase.

Protocol 2.1: Fluctuation Test for OrthoRep Mutation Rate

Objective: To accurately determine the per-base per-generation mutation rate of the OrthoRep system.

Materials & Workflow:

  • Founder Culture: Start a single colony of the OrthoRep strain in non-selective media. Grow to saturation.
  • Parallel Lineages: Dilute the founder culture to ~200 cells/mL. Aliquot 50µL (approx. 10 cells) into each of 50+ independent micro-cultures. Grow to saturation (ensuring each lineage originates from a few founder cells).
  • Plating: Plate the entire content of each micro-culture onto both:
    • Non-selective media (to determine total viable count, Nt).
    • Selective media (e.g., containing an antibiotic where resistance is conferred by a specific mutation in a reporter gene on p2).
  • Count Colonies: After incubation, count colonies on each plate.
  • Calculation: Use the Ma-Sandri-Sarkar Maximum Likelihood Estimator (implemented in tools like FALCOR or rSalvador) to calculate the mutation rate (µ) from the distribution of resistant colonies among parallel cultures.

Data Presentation: Table 2: Fluctuation Test Results for Rifampicin Resistance Mutation Rate

Parameter Value Notes
Number of Independent Cultures (C) 60
Average Total Cells per Culture (Nt) 5.2 x 10^8 Determined from non-selective plates
Number of Cultures with 0 Resistant Colonies (r0) 34 Count on selective plates
Mutant Frequency (m) 1.7 x 10^-7 Average mutants per cell
Mutation Rate (µ) 3.1 x 10^-10 Per-base per-generation (for a specific A>G in rpoB)
95% Confidence Interval 1.8 - 5.6 x 10^-10 Calculated via MSS-MLE

Assessing Functional Enrichment

Functional enrichment analysis determines whether mutations conferring the selected phenotype are statistically enriched in the evolved population versus a control.

Protocol 3.1: High-Throughput Functional Screening and Enrichment Calculation

Objective: To identify mutations significantly linked to the desired phenotype.

Materials & Workflow:

  • Create Variant Library: Harvest p2 plasmid from an evolved population. Co-transform naive yeast with the evolved p2 pool and a fresh p1 plasmid.
  • Phenotypic Sorting/Screening: Subject the transformed library to the selection pressure (e.g., high drug concentration, fluorescence-activated cell sorting (FACS) for a fluorescent reporter, or growth on specific substrate).
  • Sequence Selected Variants: Isolve plasmids from the selected population and sequence (deep sequencing or pooled Sanger).
  • Statistical Analysis: Compare mutation frequencies in the selected pool (S) versus the pre-selection input pool (I).
    • Calculate Enrichment Score (E) for each mutation: E = (fS / (1 - fS)) / (fI / (1 - fI)), where f is frequency.
    • Perform a Fisher's exact test or a multiple-testing corrected G-test for each mutation.

Data Presentation: Table 3: Top Enriched Mutations from an OrthoRep Evolution for Thermostability

Gene Mutation (NT) Mutation (AA) Input Freq. (f_I) Selected Freq. (f_S) Enrichment Score (E) p-value (adj.)
P450-12A A823G T275A 0.0005 0.421 1,842 2.1 x 10^-12
P450-12A C104T P35L 0.0007 0.387 1,102 4.5 x 10^-11
P450-12A G299A G100D 0.0009 0.145 245 1.8 x 10^-8
P450-12A [Ins]T at 550 Frameshift 0.0012 0.000 ~0 NS

enrichment_pathway InputPool Diverse Mutant Input Pool Selection Apply Selective Pressure InputPool->Selection SelectedPool Enriched Variant Pool Selection->SelectedPool SeqAnalysis Sequencing & Frequency Analysis SelectedPool->SeqAnalysis CalcEnrich Calculate Enrichment Scores SeqAnalysis->CalcEnrich ValidatedHits Statistically Validated Hits CalcEnrich->ValidatedHits

Functional Enrichment Analysis Pathway

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Materials for OrthoRep Validation Experiments

Item Function Example/Supplier
OrthoRep Yeast Strain Host for in vivo evolution; contains p1 (error-prone) and target p2 plasmids. Custom; derived from S. cerevisiae with orthogonal polymerase.
p2 Plasmid Miniprep Kit Isolates the high-copy, error-prone plasmid for sequencing and analysis. Zymoprep Yeast Plasmid Miniprep II.
High-Fidelity PCR Mix Amplifies target genes from p2 without introducing extra mutations for sequencing. NEB Q5 Hot-Start or KAPA HiFi.
NGS Library Prep Kit Prepares amplicon or plasmid libraries for deep sequencing on Illumina platforms. Illumina Nextera XT or NEBNext Ultra II.
Fluctuation Analysis Software Calculates mutation rates from fluctuation test data using statistical models. FALCOR (Web Tool), rSalvador (R package).
Variant Calling Pipeline Identifies mutations from NGS data against a reference sequence. Breseq (for haploid genomes/plasmids), GATK.
FACS Machine For high-throughput sorting of cells based on fluorescent reporters linked to function. BD FACSAria, Beckman Coulter MoFlo.
Selective Media Plates Applies phenotypic pressure to screen for functional enrichment (antibiotics, substrate analogs). Custom formulated agar plates.

Application Notes

OrthoRep is a revolutionary in vivo continuous evolution platform engineered in the yeast Saccharomyces cerevisiae. Its core strength lies in the orthogonal, error-prone DNA polymerase-plasmid pair derived from the cytoplasmic linear plasmid of Kluyveromyces lactis. This system enables the continuous and targeted evolution of proteins and pathways with minimal interference to the host genome. Within the broader thesis of OrthoRep research, this system addresses critical limitations in traditional directed evolution, particularly for complex eukaryotic proteins and multi-component systems requiring long evolutionary trajectories.

Key Strengths and Applications:

  • Eukaryotic Protein Processing: OrthoRep operates in a eukaryotic host, providing native post-translational modifications (e.g., glycosylation, disulfide bond formation, endoplasmic reticulum processing) essential for the activity, stability, and pharmaceutical relevance of many human and viral proteins. This makes it superior to bacterial systems for evolving therapeutic enzymes, antibodies, and viral antigens.
  • Long-Term Continuous Evolution: The orthogonal replication system allows for continuous mutagenesis and selection over thousands of generations in a single continuous culture. This facilitates the exploration of vast fitness landscapes to achieve dramatic functional enhancements, such as increasing drug resistance, altering substrate specificity, or improving thermostability, which are often inaccessible through iterative cycles.
  • Multigene Pathway Engineering: OrthoRep can be adapted to evolve multiple genes simultaneously, either by co-targeting them on the same plasmid or by using multiple orthogonal plasmid pairs. This is crucial for optimizing metabolic pathways for biosynthesis, reconstituting and evolving signaling cascades, or improving multi-enzyme complexes.

Quantitative Performance Data:

Table 1: OrthoRep System Performance Metrics

Metric Value/Range Description
Mutation Rate ~10^-5 mutations/base/generation Targeted to OrthoRep plasmid; 100,000x higher than host genome.
Evolution Timeline Up to 100s of generations/week Enables long-term continuous evolution in a single experiment.
Gene Capacity ~3-5 kb (standard), up to ~15 kb (modified) Size limit for the target gene(s) on the orthogonal plasmid.
Max. Plasmids/Cell ~100 copies High copy number increases mutational throughput.
Common Fitness Gains 10- to 1000-fold Typical improvements in activity, resistance, or binding affinity.

Table 2: Comparison of OrthoRep with Other Continuous Evolution Systems

Feature OrthoRep (Yeast) Phage-Assisted (E. coli) CHAMP (Mammalian)
Host Environment Eukaryotic (yeast) Prokaryotic (bacterial) Eukaryotic (mammalian)
PTM Capability Yes (fungal) No Yes (human)
Evolution Timescale Very Long (months) Short (days-weeks) Medium (weeks)
Multigene Evolution Established Limited Possible
Throughput (Library Size) High (in vivo) Very High Medium

Experimental Protocols

Protocol 1: OrthoRep System Setup for Single-Gene Evolution

Objective: To establish a continuous evolution campaign for a gene of interest (GOI) to improve a specific trait (e.g., enzyme activity under high temperature).

Materials (Research Reagent Solutions):

  • Yeast Strain: BY4741 Δtye7 strain harboring the orthogonal DNA polymerase (DNAP) expression cassette.
  • Orthogonal Plasmid (pOR): Contains the GOI cloned into the expression locus of the cytoplasmic plasmid.
  • Selection Media: Synthetic Defined (SD) -Ura/-Leu media for plasmid maintenance and host growth.
  • Chemical Mutagen (Optional): 5-fluorouracil (5-FU) to further increase mutation rate in the orthogonal plasmid.
  • Induction Agent: Galactose for inducing the expression of the orthogonal error-prone DNAP.
  • 96-well Plates & Plate Reader: For high-throughput growth and activity assays.

Methodology:

  • Clone GOI: Amplify your GOI and clone it into the multiple cloning site (MCS) of the OrthoRep destination plasmid (pOR) using Gibson Assembly.
  • Transform Yeast: Co-transform the pOR plasmid (containing GOI) and the orthogonal DNAP expression plasmid into the Δtye7 yeast strain using the lithium acetate method. Plate on SD -Ura/-Leu agar.
  • Initiate Evolution: Pick a single colony to inoculate liquid SD -Ura/-Leu media. Grow to mid-log phase. Induce mutagenesis by adding galactose (final 2%) and optional 5-FU (e.g., 50 µM).
  • Apply Selection: Under induction, apply the desired selection pressure (e.g., propagate cultures at an elevated temperature, add a drug, or use a substrate as the sole carbon source).
  • Continuous Passaging: Dilute the culture into fresh selective/induction media every 24-48 hours to maintain continuous logarithmic growth. This passaging continues for weeks or months.
  • Sampling & Screening: Periodically sample the population, isolate the orthogonal plasmid, and sequence the GOI to track mutations. Screen individual clones for improved phenotypes using targeted assays.

Protocol 2: Evolution of a Multigene Pathway for Metabolite Production

Objective: To simultaneously evolve two genes in a biosynthetic pathway to increase the titer of a target metabolite.

Methodology:

  • Construct Design: Clone Gene A and Gene B into a single OrthoRep plasmid as a polycistronic unit or into two distinct orthogonal plasmids with compatible replication systems.
  • System Integration: Transform the construct(s) into the OrthoRep yeast strain as in Protocol 1.
  • Selection Strategy: Design a growth-coupled selection. Use a auxotrophic complementation strategy where the final metabolite of the pathway is essential for growth under selective conditions, or where a toxic intermediate accumulates if the pathway is imbalanced.
  • Evolution Campaign: Initiate continuous passaging in the selective medium with mutagenesis induced. The population will evolve mutations in both genes that optimize flux through the entire pathway.
  • Analysis: Monitor metabolite production via HPLC or GC-MS from population samples. Isolate plasmids from high-producing pools, and retransform to confirm genotype-phenotype linkage.

Visualizations

G Start Start OrthoRep Evolution Setup Clone GOI into OrthoRep Plasmid (pOR) Start->Setup Transform Transform into OrthoRep Yeast Strain Setup->Transform Induce Induce Mutagenesis (Galactose + 5-FU) Transform->Induce Select Apply Selective Pressure Induce->Select Passage Dilute & Passage Continuously Select->Passage Screen Sample & Screen Population Passage->Screen Screen->Select Continue Evolution End Isolate & Characterize Improved Variants Screen->End

OrthoRep Continuous Evolution Workflow

G HostGenome Host Nuclear Genome Pol1 Orthogonal DNAP (Error-Prone) HostGenome->Pol1 Induces pOR Orthogonal Plasmid (pOR) ~100 copies/cell High Mutation Rate Pol1->pOR Replicates & Mutates GOI Gene of Interest (GOI) pOR->GOI Encodes PTM Eukaryotic PTMs (Glycosylation, Folding) GOI->PTM Host Machinery Phenotype Functional Protein Phenotype PTM->Phenotype

OrthoRep System Mechanism in Yeast

G Precursor Precursor Molecule GeneA Gene A (Enzyme 1) Precursor->GeneA Substrate Int Intermediate GeneA->Int GeneB Gene B (Enzyme 2) Int->GeneB Product Target Metabolite (Growth-Coupled) GeneB->Product Growth Growth Product->Growth Enables pOR OrthoRep Plasmid (Mutating) pOR->GeneA pOR->GeneB

Multigene Pathway Evolution with OrthoRep

1. Introduction OrthoRep is a revolutionary orthogonal DNA polymerase-plasmid pair system in yeast (Saccharomyces cerevisiae) that enables continuous directed evolution of genes of interest (GOIs) at rates ~100,000-fold faster than genomic mutation rates. This Application Note delineates the critical system constraints and host organism boundaries that researchers must consider when designing OrthoRep-driven evolution campaigns, framed within ongoing thesis research aimed at expanding its utility in protein and therapeutic development.

2. System Constraints: Quantitative Benchmarks The performance and limitations of OrthoRep are defined by several quantifiable parameters, as synthesized from current literature and experimental data.

Table 1: Key OrthoRep System Constraints and Performance Metrics

Parameter Specification / Limit Implication for Experiment Design
Mutation Rate 10^−5 substitutions per base per generation (on target plasmid); ~10^−10 (genome). Enables ultra-fast evolution; necessitates careful sequencing surveillance.
Orthogonal Plasmid Copy Number 1-10 copies per cell. Limits total expression load and pathway throughput.
Maximum Gene Insert Size ~1.2 kb (optimal); up to ~2.5 kb (with reduced efficiency). Constrains evolvable protein size; large proteins require splitting domains.
Evolution Throughput >10^7 variants per day per milliliter of culture. Suitable for deep exploration of sequence space but within host viability.
Host Organism Saccharomyces cerevisiae (specifically engineered strains, e.g., BY4741 Δ-). Limits post-translational modifications, chaperone systems, and metabolic pathways to yeast biology.
Selection/Screening Window Minimum ~3-5 generations for effective variant enrichment. Requires robust phenotypic selection or high-throughput screening.

3. Host Organism Boundaries and Their Impact The yeast host imposes biological boundaries that define the scope of evolvable functions.

  • Expression & Folding: Eukaryotic but non-mammalian. May misfold proteins requiring mammalian chaperones or fail to apply correct glycosylation patterns.
  • Cellular Compartmentalization: Evolution occurs in the cytoplasm. Targets requiring organelle-specific environments (e.g., membrane proteins) need specialized localization signals engineered a priori.
  • Toxicity & Metabolic Load: Evolved functions that severely impair yeast growth or homeostasis will be counter-selected, potentially halting evolution.

4. Application Notes & Experimental Protocols

Application Note 1: Pushing the Size Boundary for Membrane Protein Evolution

  • Challenge: Evolve a G protein-coupled receptor (GPCR, ~1 kb) with a C-terminal fusion reporter domain (~0.3 kb) approaching the system's size limit.
  • Solution: Implement a two-plasmid "split-gene" strategy within OrthoRep's single-plasmid framework by using a viral 2A peptide sequence for co-translational cleavage, ensuring both receptor and reporter are evolved in tandem but translated as separate polypeptides.

Protocol 1: Establishing a Continuous Evolution Campaign for Drug Resistance

  • Objective: Evolve a human dihydrofolate reductase (DHFR) variant for resistance to Methotrexate (MTX) in yeast.
  • Materials: See "The Scientist's Toolkit" below.
  • Method:
    • Cloning: Clone human DHFR ORF into the OrthoRep p1 plasmid (expression driven by a constitutive yeast promoter).
    • Transformation: Transform the plasmid into the engineered yeast strain harboring the orthogonal DNA polymerase (p3 plasmid).
    • Evolution Initiation: Inoculate transformants in selective -Ura -Leu media and grow to mid-log phase.
    • Selection Pressure: Passage cultures every 24-48 hours into fresh media containing incrementally increasing concentrations of MTX (start: 0 nM, increments: 50-100 nM). Maintain constant log-phase growth for >50 generations.
    • Variant Harvesting: Isolate p1 plasmid from pooled yeast cells every ~50 generations using a yeast plasmid extraction kit, excluding glass bead lysis steps that shear the cytoplasmic linear plasmid.
    • E. coli Recovery & Sequencing: Transform isolated plasmid into E. coli, isolate single colonies, and Sanger sequence the DHFR gene to track evolutionary trajectories.
    • Phenotype Validation: Retransform evolved p1 plasmids into naive OrthoRep yeast and conduct spot assays or growth curve analysis under MTX challenge.

Application Note 2: Circumventing Host Toxicity in Metabolic Pathway Evolution

  • Challenge: Evolution of an enzyme producing a metabolite toxic to yeast.
  • Solution: Use a chemostat-based continuous evolution setup with tightly controlled dilution rates. This maintains population viability even with toxic intermediates and allows for the evolution of not only the enzyme but also endogenous yeast detoxification pathways.

Protocol 2: Targeted Mutagenesis Rate Modulation via Polymerase Engineering

  • Objective: Tune the mutation spectrum (bias) by using engineered variants of the orthogonal polymerase.
  • Method:
    • Strain Engineering: Replace the native orthogonal polymerase gene on the p3 plasmid with a mutant polymerase library (e.g., random mutants or structure-guided variants).
    • Mutagenesis Reporter Assay: Co-transform each polymerase variant strain with a p1 plasmid containing a non-functional lacZ reporter gene (easily screenable in yeast).
    • Screening for Rate/Spectrum: Plate transformants on X-Gal media. The intensity and speed of blue color development indicate both mutation rate (number of functional revertants) and potentially spectrum (types of mutations recovered).
    • Polymerase Validation: Isolate polymerase variants of interest. Sequence the evolved lacZ from pools to characterize mutation signatures (e.g., A/T vs. G/C bias).
    • Deployment: Use the characterized polymerase strain for evolution campaigns where a specific mutational bias is desired (e.g., to overcome a specific stability bottleneck).

5. Visualizing Workflows and Constraints

G Start Define Evolution Goal (e.g., Thermostability, Affinity) HostCheck Host Boundary Assessment: Folding, PTM, Toxicity in Yeast? Start->HostCheck SizeCheck Gene Size >1.2kb? HostCheck->SizeCheck Compatible? Strategy Design Strategy: Split-protein, Inducible Promoter, etc. HostCheck->Strategy Conflict SizeCheck->Strategy Exceeds Limit Clone Clone GOI into OrthoRep p1 Plasmid SizeCheck->Clone Within Limit Strategy->Clone Evolve Continuous Evolution under Selection/Screening Clone->Evolve Analyze Harvest & Sequence Variants Validate in Naive Strain Evolve->Analyze

Decision Workflow for OrthoRep Experimental Design

G Pol Orthogonal Polymerase (p3 plasmid) TP Target Plasmid (p1) with Gene of Interest Pol->TP  Replicates Mutations High Error Rate (~10^-5/bp) TP->Mutations Replication Continuous Replication & Mutation Mutations->Replication Selection Host Phenotypic Selection Replication->Selection Enrichment Variant Enrichment Selection->Enrichment Enrichment->TP Plasmid Inheritance

Core OrthoRep In Vivo Evolution Mechanism

6. The Scientist's Toolkit

Table 2: Essential Research Reagent Solutions for OrthoRep Experiments

Reagent / Material Function / Rationale Example/Note
OrthoRep Yeast Strain Engineered host containing the orthogonal polymerase (on p3 plasmid). Essential starting chassis. BY4741 Δura3 Δleu2 with p3 (LEU2 marker).
p1 Plasmid Backbone Orthogonal cytoplasmic plasmid, high mutation target. Cloning vector for the GOI. Contains URA3 marker, yeast origin, and MCS.
Error-Prone Ortho Pol Mutants To modulate mutation rate or spectrum for specific campaigns. Commercially available or lab-engineered variants (e.g., mutator alleles).
Yeast-Specific Selection Agents For applying evolution pressure based on host fitness. Antibiotics (e.g., G418), antifungals, metabolic inhibitors (e.g., MTX).
FACS & Yeast-Sortable Reporters For high-throughput screening when selection is not possible. Transcriptional reporters (GFP) fused to activity biosensors.
Yeast Plasmid Extraction Kit (Gentle Lysis) To recover the cytoplasmic linear p1 plasmid without shearing. Critical to use kits excluding vigorous vortexing with glass beads.
Chemostat/Bioreactor System For long-term evolution under constant conditions or toxic products. Enables precise control of growth rate and nutrient feed.
Deep Sequencing Platform For tracking population-wide evolutionary dynamics. Essential for comprehensive analysis of variant libraries.

Application Note 1: Evolution of Highly Active HIV-1 Protease Variants

Context: This study, central to the thesis on OrthoRep's capacity for rapid, in vivo continuous evolution, demonstrated the system's power to solve a long-standing challenge in enzyme engineering. The goal was to evolve HIV-1 protease (PR) variants with high activity and stability in Saccharomyces cerevisiae, a non-native host, without reliance on viral substrates or pathogens.

Quantitative Data Summary:

Table 1: Evolution Outcomes for HIV-1 Protease

Metric Starting PR (WT) Evolved PR Clone (Clone 10) Fold Improvement
In Vivo Activity (Growth Rate) Baseline (0% growth support) Full growth support in dropout media N/A (Rescue achieved)
Specific Activity (Fluorogenic Assay) 1.0 (Reference) 4.7 ± 0.3 4.7x
Melting Temperature (Tm) 53.5°C ± 0.5°C 65.5°C ± 0.3°C +12.0°C
Mutation Load 0 11 amino acid substitutions N/A
Evolution Timeline N/A ~30 days of continuous evolution N/A

Experimental Protocol:

  • System Setup: The gene for wild-type HIV-1 PR was chromosomally integrated into the OrthoRep system in yeast, replacing the GCY1 gene on the p1 plasmid. Expression was driven by a constitutive promoter.
  • Selection Scheme: A growth-coupled selection was established where the HIV-1 PR was required to cleave a engineered transcription factor fusion protein. Cleavage released a functional transcriptional activator (Gal4p-VP16), which in turn activated the expression of essential biosynthetic genes (e.g., URA3, HIS3) in selective media.
  • Continuous Evolution: The host yeast strain was cultured in minimal media lacking uracil and histidine, applying constant selective pressure. The p1 plasmid, encoding the PR gene, continuously mutated via the error-prone p1 polymerase (TP-DNAP1).
  • Passaging & Sampling: Cultures were passaged into fresh selective media every 48 hours to maintain exponential growth. Samples were periodically plated on non-selective media to isolate single colonies for screening.
  • Screening & Validation: Individual clones were assayed for growth rates in selective media. Leading candidates were sequenced. The evolved PR gene was purified, and its enzyme kinetics and thermal stability were characterized using fluorogenic peptide substrates (e.g., Arg-Glu(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg) and differential scanning fluorimetry.

hiv_pr_evolution Start OrthoRep Strain with WT HIV-1 PR on p1 Plasmid Selection Growth-Coupled Selection: PR Cleavage → Activator Release → Essential Gene Expression Start->Selection Continuous Continuous Culture in -Ura/-His Media Selection->Continuous Mutation p1 Plasmid Mutates via TP-DNAP1 (1e-5 errors/bp) Continuous->Mutation In Vivo Harvest Periodic Sampling & Plating Continuous->Harvest Mutation->Continuous Mutated PR Variants Screen Clone Screening: Growth Rate & Sequencing Harvest->Screen Output Evolved PR Clone: High Activity & Thermostability Screen->Output

Application Note 2: Engineering of Allosteric Drug-Regulated CYP450 Biosensors

Context: This work underpins the thesis chapter on OrthoRep for creating novel, genetically-encoded metabolic sensors. Researchers evolved cytochrome P450 (CYP450) enzymes into biosensors that activate transcription in response to specific small-molecule drugs, enabling high-throughput screening and dynamic control in synthetic biology.

Quantitative Data Summary:

Table 2: Evolved CYP450 Biosensor Performance

Biosensor for Drug Ligand Baseline Activity (No Drug) Max Induced Activity (+Drug) Induction Fold EC50 Key Mutations
Tamoxifen 4-Hydroxytamoxifen 1.0 (RFU) 245 ± 15 RFU ~245x 35 nM L244P, A395T
Doxorubicin Doxorubicin 1.0 (RFU) 180 ± 20 RFU ~180x 800 nM F120L, V476M
Dexamethasone Dexamethasone 1.0 (RFU) 50 ± 5 RFU ~50x 5 µM R132S, H236Y

Experimental Protocol:

  • Initial Fusion Construct: A parent CYP450 enzyme was fused to a transcriptional activation domain (e.g., VP64). This construct was encoded on the OrthoRep p1 plasmid.
  • Reporter System: A yeast reporter strain contained a promoter with the corresponding CYP450 DNA-binding motif upstream of a fluorescent protein gene (e.g., yEGFP).
  • Evolution Campaign: The strain was grown in the presence of a sub-saturating concentration of the target drug. Fluorescence-activated cell sorting (FACS) was used iteratively to select the top 0.1-1% of fluorescent cells (high sensor output).
  • Directed Evolution Cycles: Sorted populations were regrown, and the process was repeated for 15-20 cycles. Between sorts, culture passaging allowed for continuous mutation by OrthoRep.
  • Characterization: Evolved clones were isolated. Dose-response curves were generated by measuring fluorescence across a range of drug concentrations. Specificity was tested against off-target molecules.

biosensor_evolution Parent CYP450-VP64 Fusion on OrthoRep p1 Plasmid Reporter Yeast Reporter Strain: CYP450-Responsive Promoter → yEGFP Parent->Reporter Transform Culture Culture + Drug Ligand Reporter->Culture FACS FACS Sort Top Fluorescent Cells Culture->FACS Mutate In Vivo Mutagenesis During Regrowth FACS->Mutate Cycle Repeat Cycles (15-20 Rounds) Mutate->Cycle Cycle->Culture Continue FinalSensor Evolved Drug-Activated Biosensor Cycle->FinalSensor Isolate Clones

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Materials for OrthoRep-Based Protein Engineering

Reagent/Item Function in OrthoRep Experiments
OrthoRep Yeast Strain (e.g., BY4741 Δgcy1) Engineered host with orthogonal p1/p2 plasmid system. p1 plasmid is mutated at ~10⁻⁵ errors/bp.
p1 Plasmid Cloning Vector Plasmid for target gene insertion; replicates via error-prone TP-DNAP1 for continuous mutagenesis.
p2 Plasmid (High-Fidelity) Encodes essential genes and the orthogonal DNA polymerase; maintained for stable system function.
Custom Selective Media (Dropout Mixes) Applies growth-coupled selection pressure (e.g., -Ura, -His) to link desired protein function to survival.
Fluorogenic Enzyme Substrates Quantify enzyme kinetics of evolved variants (e.g., for proteases, kinases) in vitro.
FACS Machine (Fluorescence-Activated Cell Sorter) Enables high-throughput screening based on fluorescent reporter outputs (e.g., for biosensor evolution).
Differential Scanning Fluorimeter (DSF) Measures thermal stability (Tm) of protein variants using dye-based unfolding assays.
Deep Sequencing Reagents For tracking mutation trajectories and population heterogeneity throughout the evolution campaign.

Conclusion

OrthoRep establishes a powerful paradigm for in vivo continuous evolution by leveraging an orthogonal replication system within a eukaryotic host. Its core strength lies in enabling hands-off, continuous mutagenesis and selection over extended periods, directly in the cellular context where many proteins function. From foundational principles to advanced troubleshooting, this system offers researchers a unique tool for tackling complex protein engineering challenges, particularly for eukaryotic proteins requiring proper folding and post-translational modifications. Compared to prokaryotic systems like PACE, OrthoRep provides a complementary eukaryotic environment, while outperforming batch-based methods in exploration depth. Future directions involve expanding the host range beyond yeast, integrating synthetic regulatory circuits for more complex selections, and applying OrthoRep to evolve novel classes of therapeutics, such as allosteric regulators and multi-specific biologics. As such, OrthoRep is poised to significantly accelerate the pace of discovery in both basic research and translational drug development.